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Compression is a common mechanical stimulus in our body that results from gravity 
and tissue growth. Inability for cells to maintain force homeostasis can lead to various 
diseases, and cells may experience an increase in compressive stress in diseases such as 
hypertension and cancer. Actin cytoskeleton provides structural and mechanical strength 
for cells to withstand external mechanical forces. It is also very sensitive to deformation 
and plays an important role in mechanosensing, due to the tensegrity nature of the 
cytoskeleton. Despite being an important component, actin remodeling and molecular 
signaling in response to compression have not been very well studied. From a molecular 
perspective, the actin network is regulated by actin accessory proteins into different 
structures and functions. At a cellular level, different actin networks are organized and 
regulated by various signaling pathways. At an intercellular level, cells are mechanically 
coupled that enable the transmission of force via actin networks between cells. In this 
dissertation, I investigated the sensing and transduction of compression stimulus in cells 
from molecular to intercellular scales, I developed new emerging platforms for the 
compression studies in in vitro reconstitution and single-cell system, and investigated actin 
remodeling and its related mechanisms under compression in 2D cell population. 
First, I developed an approach that combines purified actin cytoskeletal proteins or 
mammalian cell-free expression and ultra-thin double emulsion template for constructing a 
simplified model of a cell through in vitro reconstitution. This was used to study the 
 xv 
mechanical properties of a specific and isolated cytoskeleton structure. We demonstrated 
the formation of bundled actin filaments inside the lipid vesicles. By using the mammalian 
cell-free expression system, we found that actin structures inside the system were 
precipitating with the droplet stabilizing surfactant polyvinyl alcohol, leading to a 
compensation of protein production and vesicle stability. Nevertheless, this approach 
provides a simplified yet insightful cell-like model for future cell mechanics investigation.  
I also developed a pneumatic-controlled, two-layered microfluidic platform for 
applying compression and aspiration to double emulsion droplets as a model cell. I further 
improved the microfluidic device to apply controlled compression to single cells that can be 
used to study the heterogeneity of mechanical properties and responses of cells. The device 
was designed through optimization by simulation and was characterized experimentally. 
Static and cyclic compressions were applied to single cells seeded inside the device.  
Finally, I investigated actin cytoskeletal remodeling, mechanosensing and 
mechanotransduction of epithelial cells under compression, in a 2D cell population context. 
I discovered the formation of actin protrusions at the apical surface of the cells under 1200 
Pa compression. The actin protrusions were structurally similar to invadopodia but not 
functionally. Src signaling was found to be an important signaling pathway in these actin 
protrusions. This discovery opens up new direction of research and may explain why cells 
become more invasive under compression. This work could also shed light on the 
heterogeneity of cancer tissues and may inspire a new treatment paradigm. 
In this dissertation, I developed experimental platforms and studied the remodeling 
of actin networks under compression using in vitro reconstitution, single-cell and cell 
population systems, taking advantages of each experimental system. The platforms 
 xvi 
developed in this dissertation provide novel techniques for investigating actin cytoskeleton 
response of cell under compression, and the discovery of actin protrusions reported in this 
dissertation reveals a new cellular response under high compression. 
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Chapter 1: Introduction 
 
1.1 Mechanobiology  
1.1.1 Biological cell and mechanical force: When the two strangers meet 
Mechanobiology is a combination of two words. “Mechano” is a prefix that refers to 
the involvement of mechanical forces or the use of machines or mechanisms. “Biology” is a 
field of natural science that studies life and living organisms. The combination of these two 
words refers to an emerging field at the interface of biology and engineering that 
investigates how mechanical forces contribute to the responses of living organisms.  
Cells are the building blocks of life. A cell provides the basic structural, functional 
and biological unit of living organisms. It is highly responsive and adaptive to the 
surroundings and can replicate independently. Cells were discovered by Robert Hooke in 
1665 [1] and the theory of cell was later formulated by Theodor Schwann and Matthias 
Schleiden in 1839 [2]. The understanding of how cells behave, respond and adapt to the 
environment is still under intense research at this moment.  
Force, on the other hand, describes the rule that govern the entire physical world. It 
is an interaction that when unopposed will change the motion of an object. It was described 
by Sir Isaac Newton in 1687 [3], and later was known as the Newton’s Laws. The Newton’s 
second law states that the net force acting upon an object is equal to the rate at which its 
momentum changes over time. Pressure, defined as the distribution of forces applied over 
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an area of a body, is a stress that if unbalanced can causes deformation in solid materials or 
flow in fluids.  
If we consider cells as a complex material with viscoelastic properties, then there is 
no doubt that when a force is applied, the cell will undergo partial deformation and partial 
flow, just like what a partially solid and fluid material will behave. However, cell is more 
than a complex material. Many early biologists recognized the importance of physical 
forces and shapes in the development and function of organisms. Later, biologists realized 
that cellular behaviors do not purely depend on the encoded DNA information inside the 
cell. The behaviors of cells also depend on the mechanical properties of the extracellular 
environment and the physical forces that the cell experiences [4].  
Indeed, cells interact with the surrounding microenvironment and respond 
accordingly, including not only chemical stimulation such as hormones, but also physical 
stimulation such as another neighboring cell or the extracellular matrix. The elasticity and 
stiffness of the extracellular matrix are critical for normal cell function [5, 6]. The same 
chemical stimulation will result in different responses when the mechanical properties of 
the extracellular matrix are altered. The matrix elasticity was shown to be very important 
for stem cell differentiation [7]. Any deregulation of the extracellular matrix properties 
could result in diseases like cancer or fibrosis [8, 9]. Apart from the extracellular matrix, 
other forms of physical stimulation are mechanical forces that act directly on cells, for 
example solid compressive and tensile stress during muscle contraction or lung expiration 
and inspiration [10], and fluid shear stress during air breathing and blood flow [11]. Both 
extracellular matrix properties and forces are crucial in tissue homeostasis and 
development especially during embryonic development [12, 13]. With the different kinds of 
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physical stimulations that cells sense and respond to, more research has focused on 
studying how physical forces and change in mechanical properties of cells and tissues 
contribute to development, cell differentiation, physiology and disease. 
 
1.1.2 Mechanosensing and modes of mechanotransduction: To pull or be pulled 
The study of mechanotransduction in cells is an essential focus in mechanobiology. 
Mechanotransduction converts mechanical stimuli into biochemical signals that alters 
cellular behaviors. Typically, mechanotransduction involves mechanosensing of the 
external stimuli by focal adhesions, mechanosensitive ion channels, cell-cell contacts, actin 
cytoskeleton, or receptors on the plasma membrane. Subsequently, these mechanosensors 
convert the mechanical stimuli into biochemical signals that change protein-protein 
interactions and eventually alter gene expression profiles, resulting in different cellular 
behaviors and functions. 
Cells sense different kinds of mechanical stimuli, for example extracellular matrix 
stiffness, compressive and tensile stress, and shear stress. While we start to understand the 
cellular responses to different mechanical stimuli, researchers find that cellular responses 
to different mechanical stimuli appear to be similar at times but different at other times. 
Some of the mechanotransduction pathways are shared and some are distinct. Recently, a 
new framework was developed to describe the multiple modes of mechanotransduction 
and provide a useful starting point for identifying overlaps in molecular players and 
sensing modalities [14]. Mechanical stimuli can be described as either ‘active’ or ‘passive’, 
where active input refers to the direct force acting on cells that leads to deformation while 
passive input refers to physical properties of the environment that the cell pulls against. On 
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the other hand, cellular responses can be described as either ‘material’ or ‘biological’ 
responses, where material response refers to non-living material response like stress 
stiffening or viscoelastic creep while biological response refers to behavioral outputs that 
involve energy consumption or the conversion of mechanical signals into biochemical 
signals like the assembly of cytoskeleton, signal transduction or gene expression. 
 
1.1.3 in vitro reconstitution, single-cell and cell population mechanobiology study: From 
simplicity to complexity 
Different biological systems can be used for mechanobiology studies such as in vitro 
reconstitution, single cell, cell population, tissue or even animal model. The more simplified 
the system is, the better we can understand the specific roles and functions of the 
individual components within a simplified system. In contrast, the more similar the system 
is to our body, the more physiologically relevant it is, but the biology becomes increasingly 
complex. Each of these systems has their own advantages and provides unique insight to 
our understanding.  
The cytoskeleton network is compartmentalized and heterogeneous within a cell 
[15]. The network is also highly dynamic, so that mechanical perturbation could change the 
cytoskeleton structure and mechanical properties of the cell. One approach to study the 
mechanical properties of different types of cytoskeleton networks is through in vitro 
reconstitution [16]. Studying in vitro reconstituted cytoskeleton networks may yield 
understanding of the mechanical properties, functions and behaviors of the simplified and 
isolated network.  
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For single cell study, individual cell with different actin structures is investigated. 
Signaling pathway, transcription and translation are also involved in determining the 
response of the actin cytoskeleton (e.g. by expressing a particular actin binding protein) 
inside the cell. Recently, single cell study is gaining more attention, since it allows us to 
investigate cell to cell variability. Each cell in a tissue may be different and has 
heterogeneous mechanical properties [17]. Mechanobiology study of single cells allows one 
gain insights on the heterogeneous responses of single cells to mechanical signals. 
For cell population study, a group of cells is investigated. Since cells interact with 
their surroundings and pull against them, the microenvironment context that the cells are 
in becomes the passive mechanical input and affects cellular functions and behaviors. It has 
been shown that petri dish cell culture cannot recapitulate the functions found in live 
tissues [18]. Different engineering tools have been developed to manipulate cell 
populations and investigate their mechanical response [19]. By considering the 
interactions and force transmission between cells, cell population study of mechanobiology 
allows the understanding of how intercellular forces affect cellular responses.  
in vitro reconstitution, single-cell and cell population methods all have merits for 
understanding the mechanical responses of cells from different angles. Together, they offer 
tremendous insights in mechanobiology. 
 
1.1.4 Discovery of mechanotransduction and development of tools: The inseparable unity 
To understand how cell transduces the mechanical inputs into material or biological 
outputs, new engineering tools are necessary to help apply physical forces to cells and alter 
the mechanical properties of the extracellular matrix. Throughout the history of 
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mechanobiology research, the discovery of mechanotransduction and the development of 
engineering tools are closely related. New engineering tools developed have enabled many 
new mechanotransduction discoveries. 
After the discovery of focal adhesions and actomyosin contraction [20-23], a new 
tool was needed to measure the contractile force that a cell pulls on the extracellular 
matrix. Silicone rubber substrata was developed to visualize the traction force that the cells 
exert to the substrate [24] and the technique was improved by incorporating fluorescent 
beads to determine quantitative maps of traction forces [25]. This allows the measurement 
of traction forces in migrating cells [25] and the tension at cell-cell contacts [26].  
As we knew that cells exert traction forces on the extracellular matrix and tension 
on neighboring cells, new engineering techniques were developed to study whether the 
change in passive inputs, like the properties of the substrate that cells pull against, would 
alter the cellular behaviors and functions. By changing the crosslinking properties of 
acrylamide gels, the stiffness of the extracellular matrix changes. It was found that cell 
locomotion and focal adhesions are regulated by substrate stiffness [27]. By using an 
elastomeric stamp of defined features, defined shape and size of extracellular matrix can be 
created to dictate cell spreading [28]. It was found using this technique that cell shape 
governs whether individual cells grow or die [29]. A micropillar array technique was 
developed to manipulate and measure the mechanical interaction between cells and their 
underlying substrates [30]. This technique allows the modulation of substrate rigidity 
while keeping other substrate properties constant. It was demonstrated that micropillar 
rigidity impacts cell morphology, focal adhesion, cytoskeletal contractility and stem cell 
differentiation [31].  
 7 
Other than the development of new tools to manipulate passive inputs, researchers 
developed new tools for the application of active inputs to molecules and cell, such as 
externally applied forces and displacement, fluid shear, osmotic pressure and acoustic 
waves. For instance, magnetic tweezer uses magnetic field to apply local forces to magnetic 
beads bound to a cell [32]. By attaching the magnetic beads to integrin receptors and 
applying stress to the integrin molecules, it was found that the mechanical signals were 
transmitted to the cytoskeleton and the cytoskeletal stiffness increased [32]. Recently, 
magnetic tweezers was used to reveal mechanical plasticity of cells [33]. Atomic force 
microscopy was developed to manipulate and measure forces and displacements on 
biomolecules or cells [34, 35]. By measuring the deflection of a cantilever that is in contact 
with a cell, the displacement or force can be calculated. This technique allows the 
understanding of domain folding and refolding, and the elastic properties of different 
proteins [36-38]. Optical tweezer was developed to apply forces to biomolecules by 
providing attractive or repulsive force to move microscopic dielectric objects [39, 40]. It 
was used to apply restraining force on cells. As a result, the integrin-cytoskeleton linkages 
were found to strengthen locally [41]. Microfluidics, a more recent technology that 
manipulates fluids at the submillimeter scale [42], has provided a suitable platform for 
studying mechanotransduction. It allows the application of shear stress, interstitial flow, 
stretching and confinement to the cells [43] and opens numerous opportunities for 
different mechanotransduction studies [44-46].  
Overall, the development of new engineering tools provided platforms for applying 
passive and active mechanical inputs to cells in a well-controlled manner [47, 48]. This has 
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opened more opportunities for mechanotransduction studies and enables more in-depth 
understanding of how cells respond to different mechanical stimuli. 
 
1.2 Compression 
1.2.1 Active mechanical signal: The physiological pushing 
Cells and tissues in our body experience all kinds of chemical and active mechanical 
signals in physiological and pathological conditions. Due to the complex environment and 
multiple interactions with neighboring cells, cells experience different combinations of 
compressive, tensile and shear stresses in different directions. Cells have been isolated 
from the complex tissue environment and a specific type of stress was applied to the cells 
to determine how each of these stresses is sensed by the cells and how the specific 
mechanical signal is transduced inside the cells. 
The study of biological responses to compression, tension and shear have a long 
history, particularly in musculoskeletal [49] and vascular [50, 51] tissue. However, there is 
a growing interest in studying mechanotransduction from compressive stress in other 
physiological environments, for example during development [52] and in cancer [53].  
 
1.2.2 Compression in physiological and pathological conditions: When force goes wrong 
Compression is a very common type of mechanical signal in our body. Due to our 
body weight, cells and tissues support our body weight, like bone, experience different 
extent of compression. Compression and other mode of mechanical loading affect the 
behavior of bone cells, which in turn may alter the homeostasis of bone [54, 55]. However, 
when cells and tissues are subjected to sustained compression, it can cause cell 
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deformation, tissue breakdown and inflammation [56]. Pressure ulcers are developed in 
tissues that are subjected to sustained mechanical loading [57]. Other diseases, such as 
hypertension, embolism and acute angle-closure glaucoma, are other examples of the 
development of compression in our body [58, 59]. Compression is also developed in the 
tumor microenvironment. Due to the confined microenvironment and the uncontrolled 
division of cancer cells, compression builds up in the tumor and the surrounding normal 
tissue [60]. Since an increase in compression is common in many different diseases, it is 
important to study the response and mechanism of cells under compression, so that we can 
have a holistic understanding of the diseases.  
 
1.2.3 Material response of actin cytoskeleton: Complex elastic solid and viscous fluid property 
Material response is the non-living response of the cell, like stress stiffening and 
viscoelastic creep. Under compressive load, any solid elastic material will deform. The ratio 
between the applied compressive stress and the deformed strain is the elastic modulus of 
the solid material. For a Newtonian fluid, compression results in constant deformation. The 
ratio between the applied compressive stress and the deformation rate is the viscosity of 
the fluid. Cell has a mechanical property that is in between that of an elastic solid and a 
pure Newtonian fluid, and thus is viscoelastic. The viscoelasticity of a cell is mainly due to 
the properties of actin cytoskeleton. Actin cytoskeleton is a network of actin filaments and 
crosslinking proteins that provides structure and mechanical strength of a cell. Through 
spatiotemporal coordination with a variety of actin binding proteins, actin assembly drives 
movement of a cell. Due to the complex structure of the actin cytoskeleton, the mechanical 
properties and material behavior of the actin networks are still under intense research in 
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order to fully understand how cells regulate cell shape and generate mechanical forces 
[61].  
The viscous effect of the actin network is due to the dynamic and finite binding 
affinity of crosslinker to actin filaments [62-64]. The easier or more frequent the 
crosslinkers dissociate from the actin filaments, the more viscous the actin network will be. 
The time scale at which the mechanical stress is applied to the cell will determine whether 
the elastic or viscous effects dominate. For short loading time scale, the crosslinkers remain 
bound to the actin filaments and therefore, elastic effect dominates. On the contrary, for 
long loading time scale, the unbinding and rearrangement of crosslinkers can lead to stress 
relaxation and the accommodation of cell shape change, and therefore displaying a viscous 
effect [33]. Apart from the time scale at which the mechanical loading was applied, the 
mechanical response of the actin cytoskeleton network will become nonlinear at large 
stress or strain. Therefore, the stiffness of the actin network depends on the magnitude of 
the applied stress or strain. In general, low actin density network will soften at large strain, 
while high actin density network will stiffen at intermediate strains and dramatically soften 
at larger strains [65-67].  
The above studies were mostly carried out in a reconstituted environment without 
confinement. Therefore, they may not reflect the response of cells, in which actin 
cytoskeleton is confined inside the plasma membrane. However, similarly, the material 
response of cells under compression will be determined by the stress and strain level, the 
time scale at which compression was applied, and the dissociation property of crosslinkers 
in the actin cytoskeleton. The study of how actin cytoskeleton responds to mechanical 
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compression can provide insight into how cells withstand mechanical compression and 
how they regulate their shape under compressive loading. 
 
1.2.4 Biological response of actin cytoskeleton: To overcome the force 
The actin network inside living cells are not at equilibrium [68]. It constantly 
changes due to the biological signals that control the assembly, architecture and 
mechanical properties of actin networks in different parts of the cells through the 
regulation of cross-linking protein affinity, activity of myosin-II and actin filament assembly 
[61]. For example, the stiffness of an actin network can be altered by myosin activity, 
through phosphorylation of its regulatory light chain [69, 70]. These biological signals can 
be a response to mechanical stimulations, so that the assembly, architecture and 
mechanical properties of actin networks change in response to mechanical deformation. 
Cyclic stretching can lead to the reinforcement and fluidization of actin cytoskeleton [71]. It 
was later found that the reinforcement of actin networks under cyclic stretching was due to 
the phosphorylation of a small heat shock protein HspB1 through a p38 MAPK-dependent 
pathway [72]. Fluid shear stress also changes cell shape and alignment through actin 
network remodeling in the direction of flow [73]. Apart from cyclic stretching and fluid 
shear stress, cyclic compression of human mesenchymal stem cells embedded in collagen 
also leads to the change in assembly and architecture of the actin networks [74]. 
Mechanoresponsive, omni-directional and local matrix-degrading actin protrusions were 
formed at the membrane of human mesenchymal stem cells under cyclic compression. The 
actin protrusions were found to be similar to filopodia and invadopodia in morphology and 
composition, but different in stability, abundance, signaling and function. Altogether, these 
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studies showed that actin cytoskeleton plays an important role in eliciting biological 
signaling when mechanical forces were exerted. 
 
1.3 Emerging experimental platforms for studying mechanobiology of compression 
1.3.1 Membrane-confined bottom-up reconstitution: A simplified yet insightful approach for 
mechanobiology 
The structure of a cell is complicated, and there are a lot of biological pathways 
involved inside cells that change the ways cells respond constantly. When we measure the 
mechanical properties of the cell, a measurable force is applied to the cell and the 
deformation of the cell is observed under the applied force. However, cell is a living entity 
that responds to the force that it experiences. It is difficult to uncouple the material 
response and the biological response of a cell under a mechanical loading. Therefore, in 
vitro reconstitution has been used as a platform for understanding how different 
cytoskeletal structures respond to forces separately [16]. For example, actin networks have 
been reconstituted and an atomic force microscope has been used to apply a force and 
measure the network deformation. It was found that the growth velocity of an actin 
network depends on the force that was applied to the network while it was growing [75]. 
The structure and mechanical properties of the actin network also changed with the 
mechanical loading [76]. However, the networks were reconstituted in a biochemically 
opened environment that failed to capture the compartmentalized nature of cellular actin 
networks. 
Membrane-confined bottom-up reconstitution is an engineering approach to 
encapsulate reconstituted cellular structures inside lipid vesicles. The reconstituted 
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cellular structures are confined inside a lipid membrane, in which biophysical and 
biochemical conditions will be different from bulk structures. For example, there will be 
limited nutrients for the biological activity. Diffusion is confined within the lipid vesicle. 
Interactions can also be engineered between the cellular structure and the lipid membrane 
to reconstitute interactions inside living cells. Besides, with the advancement of cell-free 
expression systems, encapsulation of cell-free expression system within lipid vesicles allow 
the construction of cell-like model that recapitulate the structure, mechanical properties 
and potentially the response of living cells under mechanical loading. Membrane-confined 
bottom-up reconstitution is a simplified yet insightful approach for studying the mechanics 
of cell.  
 
1.3.2 Microfluidics: Promising microtechnology for the study of mechanobiology 
The development of novel microtechnology techniques and tools had been essential 
for the study of mechanobiology. For example, the use of elastic silicone surfaces as a 
substrate for cell spreading [24] and the further development into traction force 
microscopy [25] revealed that cells produce force to the substrates that they attach to. 
Additional tools were introduced for the application of active forces to cells. The 
development of atomic force microscopy [36], optical trap [41] and magnetic tweezers [77] 
have provided detailed understanding of mechanosensing at the molecular level. While the 
above novel microtechnology techniques apply active forces to cells through specific 
proteins or lipids, recently, different studies used modified atomic force microscopy probes 
for the application of compressive forces to single cell [78, 79]. While atomic force 
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microscopy is a powerful approach to apply compressive forces and measure deformation 
of cells, the method has a low throughput and requires specialized skills.  
Microfluidics is a promising microtechnology that utilizes microchannels with 
dimensions of tens of micrometers to manipulate small amounts of fluid [80]. It allows the 
use of small sample and reagent quantities, relatively lower cost and higher throughput. A 
small channel also enables small Reynolds number laminar flow, which is more 
controllable. The material used for building microfluidic devices (i.e. PDMS) is also 
biocompatible, making microfluidics a good platform for biological studies [42].  
Microfluidics has been used for the study of mechanobiology [43] by providing a 
means to apply shear stress, interstitial flow, stretching and confinement to the cells [44-
46]. For compression of cells, the development of switching valves in microfluidic devices 
[81] led to several high throughput platforms to study lysis of cells [82], injury of axons 
[83] and growth of E. coli [84] under compression. However, the microvalves microfluidic 
platform has not been developed for the application of compression to single cells, which 
could provide a more precise understanding of the heterogeneous responses of each cell 
under compression.  
 
1.4 Dissertation outline 
Mechanical compression is a common and important type of mechanical signal in 
our body. However, unlike fluid shear stress and stretching, the material responses and 
molecular responses of cells under compression are still not very well understood. This is 
in part due to the fact that the experimental platform for studying mechanotransduction of 
compression in single cells is still underdeveloped. From past history, we know that both 
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the discovery in mechanotransduction and development of engineering tools come hand-
in-hand. Moreover, the study of mechanobiology in in vitro reconstitution, single cell and 
cell population each uniquely contributes to our understanding of mechanobiology and as a 
whole bridge together to form a more complete picture. Considering these aspects, the goal 
of this dissertation is to further study the actin cytoskeleton response of cell under 
compression through the development of emerging platforms. I will first develop tools and 
study the mechanotransduction of compression in in vitro reconstitution system, and then 
from there I will move to single-cell and cell monolayer systems. Each of these systems 
provide insights into the effect of compression on actin network alone, in a single cell and 
in a cell monolayer.  
Specifically, I will first demonstrate a membrane-confined bottom-up reconstitution 
platform for constructing a simplified model of a cell in Chapter 2. The simplified model of a 
cell has a lipid membrane encapsulating actin networks or cell-free expression system for 
cell mechanics study. In Chapter 3, I will develop a valve-based microfluidic platform for 
applying mechanical forces to a simplified model of a cell and mechanically activating it. 
Chapter 4 will describe my effort to improve the microfluidic compression device for 
single-cell compression study. The device offers the potential for studying the 
heterogeneity of single-cell mechanics. In Chapter 5, I will describe my discovery of actin 
protrusions under static compression in a cell monolayer system. The compression of cell 
monolayer provides us insight into the responses of a population of cells that experience 
normal compression. Finally, Chapter 6 will summarize the contributions of this 
dissertation and suggest potential future research directions.  
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Chapter 2: Constructing a simplified model of a cell 
for cell mechanics study 
 
* Part of this chapter has been published in Ho et al., Methods in Cell Biology, 2015 and Ho et al., PLoS One, 2017. 
 
2.1 Introduction 
2.1.1 Bottom-up reconstitution  
Biological processes can be studied in the context of a whole cell or in biochemical 
reconstitution in vitro. Both methodologies have advantages and disadvantages. By using 
whole cells, the biological process can be studied and understood in a physiologically 
relevant context. Often, this involves genetic manipulation or drug perturbation to the cells 
and monitoring cellular responses. Even without manipulation, the inherent complexity of 
intracellular subsystems and signaling pathways gives rise to possible unknown factors 
influencing the components under study as proteins rarely play a single role in a single 
process.  
To simplify the study of intracellular events, researchers have been able to 
reconstitute many major subcellular functions in vitro through a bottom-up approach, and 
this has led to deeper understanding of many processes. However, in vitro reconstitution of 
spatially organized processes has been more challenging as many of these processes are 
membrane-based and require an enclosed environment. Bottom-up reconstitution of 
protein encapsulated lipid bilayer vesicles provide an enclosed, defined environment and a 
robust platform to study desired biological functions and properties. Lipid bilayer vesicles 
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encapsulating reconstituted proteins are similar to cells that are also enclosed by a lipid 
membrane.  
 
2.1.2 Simplified model of a cell for cell mechanics study 
To advance our understanding in cell mechanics, different cellular components have 
been reconstituted separately in vitro using a bottom-up approach for deeper 
understanding of their mechanical properties [85-87]. Among them, the study of the 
material properties of actin networks and their responses under force benefited from a 
bottom-up approach. Actin cytoskeleton is a network of actin filaments organized by actin-
binding proteins. It was found that with different cross-linking or bundling actin-binding 
proteins, the actin networks formed had different elastic behaviors [65, 88, 89]. With the 
help of atomic force microscopy, the force loading history plays an important role in the 
material properties of the actin networks [75, 76, 90]. While the reconstitution of different 
actin networks provides a controllable platform for the study of actin network mechanics, 
such as those that employed with atomic force microscopy, the networks are in a 
biochemically opened environment that fails to capture the compartmentalized nature of 
cellular actin networks. 
Cell-free expression (CFE) system is a biomolecular in vitro transcription and 
translation system using translation machinery extracted from cells. It holds tremendous 
promise as the cytosol of artificial cells. Development of CFE has been driven by a growing 
demand for an efficient and simple protein production method [91]. As a cell-free system 
where cell viability and survival does not need to be considered, CFE only produces 
protein(s) of interest. With the advances made in cell-free protein expression over the 
 18 
years [91], several groups have been able to encapsulate a bacterial CFE system inside 
liposomes and demonstrated expression of proteins within the liposome [92-95]. As the 
development of CFE matures and its use becomes more widespread, there is more interest 
in the use of mammalian CFE. For the production of proteins of eukaryotic origins with 
proper post-translational modifications, mammalian CFE is more advantageous over 
bacterial CFE. HeLa cell-derived in vitro coupled transcription/translation system with 
supplemented transcription and translation factors has been developed [96, 97]. The 
mammalian CFE system offers a more powerful system to synthesize more complex 
proteins, such as mechanosensitive membrane proteins. 
Toward reconstituting an artificial cell that is comparable to the membrane-bound 
and compartmentalized properties of a cell, I propose the construction of a simplified 
model of cell, which can also be used for cell mechanics study. The simplified model of cell 
is comprised of a lipid bilayer membrane, providing an enclosed and defined environment 
and encapsulating a complex protein solution (Figure 2-1). The goal of this chapter is to 
develop and construct a simplified model of a cell that could be used for cell mechanics 
Figure 2-1: Schematic of a simplified model of a cell 
(Left) Proteins self-assemble inside the simplified model of a cell to form a network 
of proteins. This changes the overall mechanical properties. (Right) New proteins 
(e.g. mechanosensitive channels) are synthesized inside the simplified model of a 
cell, to confer mechanosensitive functions. 
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study. I will first describe the development of double emulsion template for the generation 
of lipid vesicles. Then, I will describe the encapsulation of actin networks and mammalian 
CFE system inside the double emulsion templated lipid vesicles.  
 
2.2 Materials and methods 
2.2.1 Ultra-thin double emulsion templated lipid vesicles 
Ultra-thin aqueous-in-oil-in-aqueous double emulsions were used as a template for 
the formation of lipid vesicles. The middle oil phase consists of a volatile oil separating the 
inner encapsulated aqueous phase and the outer aqueous phase. Phospholipids dissolved 
in the middle oil phase tend to self-assemble and form monolayers on the aqueous-oil and 
oil-aqueous interfaces, which stabilize the emulsions. When oil begins to evaporate, it will 
de-wet the lipid interface. A vesicle will form when all the oil evaporates (Figure 2-2). 
Ultra-thin oil phase was used to reduce the oil evaporation time. The evaporation of middle 
oil phase cannot be too fast because the double emulsions could burst and this would 
reduce the yield. The double emulsions were kept in a closed environment with slow 
evaporation to form lipid vesicles. 
Figure 2-2: Schematic of double emulsion templated lipid vesicle formation. 
The evaporation of volatile oil drives the formation of lipid vesicles from double 
emulsions. 
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2.2.1.1 Fabrication of ultra-thin double emulsion device 
Double emulsions can be generated in a glass microcapillary device [98]. The glass 
microcapillary device was modified so that double emulsions with ultra-thin shell can be 
generated [99]. The schematic of the ultra-thin double emulsion device is shown in Figure 
2-3A. 
The device was fabricated by assembling tapered round capillary, square capillary 
and syringe needles together using 5 minutes epoxy [99, 100]. First, a round capillary 
(Sutter Instrument B100-58-10) was pulled using a pipette puller (Sutter Instruments P-
87) into a tapered shape. The inner diameter of two tapered capillaries were modified 
using 1200 grade sandpaper to obtain inner diameters of 50 and 80 µm for the injection 
tube and collection tube respectively. The inside surface of the injection tube was treated 
with trichloro(1H,1H,2H,2H-perfluorooctyl)silane to render the surface hydrophobic. Then, 
the injection tube and collection tube were inserted into a square capillary (AIT, 810-9917) 
placed on a glass slide and were aligned using an optical microscope. Another round 
capillary was pulled above a fire flame to form two long and thin pipettes to obtain an outer 
diameter of around 200 µm. One pulled pipette was inserted into the back of the injection 
tube and aligned using the optical microscope. Syringe needles (McMaster Carr, 
75165A677) were cut and glued to the glass slide using 5 minutes epoxy (Devcon, 14250). 
At last, microtubings (Scientific Commodities, BB31695-PE/5) were connected to the 
syringe needles. The step-by-step instructions for building the microfluidic device is shown 
in Figure 2-3B. The tapered capillaries have to be coaxially aligned inside the square 
capillary, and the inner surface of the injection tube has to be treated such that it is 
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sufficiently hydrophobic to prevent wetting of the capillaries by the aqueous phase and 
disturbing the fluid flow. A well fabricated double emulsion device can be used to generate 
ultra-thin double emulsions for over two months. 
 
Figure 2-3: Schematic and fabrication of glass capillary microfluidic device. 
(A) Schematic of ultra-thin double emulsion device. (B) Step-by-step instructions on 
building double emulsion device. (i, ii) Square glass capillary is glued to the device 
platform made of two glass slides. (iii) Two tapered round capillaries are sanded to 
modify the diameter of the openings. (iv, v) The two round capillaries are inserted 
inside the square capillary and glued to the glass slide. (vi, vii) Another round 
capillary is pulled under frame and inserted into one of the round capillary. (viii) 
Syringe needles are cut and glued onto the device and serve as the inlets of the 
device. 
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2.2.1.2 Formation of ultra-thin double emulsions 
Three syringe pumps (New Era Pump Systems, NE-500) were used to pump inner, 
middle and outer solutions into the glass capillary droplet microfluidic device for the 
formation of double emulsions (Figure 2-4A). When the flow was adjusted correctly, the 
fluid will break and form aqueous-in-oil-in-aqueous double emulsions in the dripping 
regime [101, 102]. Ultra-thin double emulsion generation was imaged using a high-speed 
camera (Phantom Miro eX2) at 3000 fps on an Olympus inverted microscope. The optimal 
flow rates of the inner, middle and outer solutions for successful formation of aqueous-in-
oil-in-aqueous double emulsions depend on various factors, including the glass capillary 
geometry, viscosities and densities of the three solutions. Typical initial flow rates of 200 
µL/h, 200 µL/h and 2400 µL/h were used for the inner, middle and outer phases 
respectively, while the flow rates were adjusted based on the emulsions formed. Ultra-thin 
double emulsions were formed successfully as shown in Figure 2-4B. 
 
Figure 2-4: Schematic for the formation of ultra-thin double emulsions. 
(A) The microtubings connect the three syringes containing inner, middle and outer 
phases are to the glass capillary and syringe needles in the way shown. (B) Image of 
ultra-thin double emulsion formation using the glass capillary microfluidic device. 
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2.2.2 Encapsulation of reconstituted actin networks in double emulsion templated vesicles 
Actin filaments can organize into different actin networks by binding and 
copolymerizing with different actin-binding proteins. For example, to form branched actin 
networks or parallel actin bundles, actin monomers are copolymerized with Arp2/3 
complex, nucleation promotion factor and capping proteins, or α-actinin and fascin 
respectively in the presence of ATP. The polymerization of actin filaments occurs within 
minutes and the polymerized actin filament network would alter the formation of double 
emulsions inside the microfluidic device. Therefore, a glass capillary microfluidic device 
that allows two different solutions to be mixed together just before being encapsulated 
inside the double emulsions was designed (Figure 2-5A). The two different solutions 
composed of the reaction components, including actin monomers, actin-binding proteins 
and polymerization buffer, where the actin monomers are separated from the actin-binding 
proteins and polymerizing buffer. The concentration of different regulatory proteins and 
actin monomers can be changed easily by changing the inner phase solution, and this 
provides us a platform to form different actin networks inside the vesicles (Figure 2-5B).  
The inner solution consisted of actin solution and polymerizing buffer solution. The 
actin solution was composed of 4 µM Rhodamine-labelled actin, 1X G-buffer, 2% polyvinyl 
alcohol (PVA), 8% polyethylene glycol (PEG), 15 mM creatine phosphate, 125 nM fascin 
and 138 µM sucrose. The polymerizing buffer solution was composed of 1X G-buffer, 2X F-
buffer, 2% PVA, 8% PEG and 182 µM sucrose. The middle phase was a mixture of 
chloroform/hexane at a ratio of 36:64 (vol/vol). 7 mM of lipids with compositions of 65.8% 
DOPC, 30% cholesterol, 0.2% 16:0 Liss Rhod PE or 34.8% DOPC, 34.7% DPPC, 30% 
cholesterol, 0.5% 16:0 NBD-PE and 4% PEG2000 were dissolved in the solvents. The outer 
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solution composed of 10% PVA with 300 mM of glucose. The osmolarities of the inner and 
outer solutions were measured by using 5600 Vapro Vapor Pressure Osmometer 
(ELITechGroup) and were balanced. Flow rates of 150 µL/h, 150 µL/h, 400 µL/h and 2600 
µL/h were used for the actin solution, polymerizing buffer solution, middle and outer 
phases respectively. 
 
Figure 2-5: Schematic for the encapsulation of reconstituted actin networks in 
double emulsion templated vesicles. 
(A) Modified glass capillary microfluidic device that allows the mixing of two 
components just before being encapsulated inside the double emulsions for the 
formation of lipid vesicles. (B) With different actin-binding proteins copolymerized 
with actin monomers, actin cortex, actin bundles or branched actin network can be 
formed. 
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2.2.3 Encapsulation of mammalian cell free expression system in double emulsion templated 
vesicles 
The mammalian cell-free expression system is a mixture of six different solutions 
(Figure 2-6), each described below. HeLa lysate was prepared according to previously 
published procedures [100]. DNA constructs encoding GADD34 and T7 RNA polymerase 
were obtained from H. Imataka (University of Hyogo, Japan) and purified following 
previously established protocols [96, 97]. Mix 1 has a composition of 27.6 mM Mg(OAc)2 
and 168 mM K-Hepes (pH 7.5). Mix 2 has a composition of 12.5 mM ATP, 8.36 mM GTP, 
8.36 mM CTP, 8.36 mM UTP, 200 mM creatine phosphate, 7.8 mM K-Hepes (pH 7.5), 0.6 
mg/mL creatine kinase, 0.3 mM amino acid mixture, 5 mM spermidine and 44.4 mM DTT. 
MscL-eGFP was cloned into pT7CFE vector (ThermoFisher). Mammalian CFE reactions 
were prepared by first mixing 9 µL lysate, 2.25 µL Mix 1 and 2.7 µL GADD34 (to give a final 
concentration of 310 nM) and incubated at 32oC for 10 min. Then, 2.25 µL Mix 2, 1.8 µL T7 
RNA polymerase (to give a final concentration of 450 nM) and 1.5 µL DNA (500 ng) were 
added to form the complete CFE reaction and incubated at 32oC for 5 hr. Larger total 
Figure 2-6: Schematic of mammalian cell-free expression system 
HeLa mammalian CFE system is a combination of HeLa lysate, Mix 1 buffer, GADD34, 
T7 RNA polymerase, Mix 2 accessory factors and DNA plasmid containing T7 
promoter. 
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volume was also used for the encapsulation in lipid vesicles while all the volume ratios 
remained the same. 
The inner solution consisted of the mammalian CFE with 2% surfactant (PVA or 
Pluronic surfactant) and 2 mM of fluorinated surfactant F6-TAC. The middle phase was a 
mixture of chloroform/toluene or chloroform/hexane at a ratio of 36:64 or 40:60 (vol/vol). 
Lipid compositions of 69.5% DOPC, 30% cholesterol and 0.5% 16:0 Liss Rhod PE or 34.8% 
DOPC, 34.7% DPPC, 30% cholesterol and 0.5% 16:0 Liss Rhod PE were dissolved in the 
solvents. The outer solution composed of 10% PVA with 20 mM K-Hepes (pH 7.5), 150 mM 
KCl and glucose. The osmolarities of the inner and outer solutions were measured by using 
5600 Vapro Vapor Pressure Osmometer (ELITechGroup) and were balanced. Flow rates of 
200 µL/h, 200 µL/h and 2400 µL/h were used for the inner, middle and outer phases 
respectively. 
 
2.2.4 Microscopy and imaging 
Brightfield or fluorescence images were obtained on a Nikon inverted microscope 
(TiE) or on an Olympus spinning disk confocal microscope (IX73 with Yokogawa CSU X1). 
 
2.2.5 Protein identification by LC-tandem mass spectrometry   
HeLa CFE were incubated at 32oC for 5 hours with different PVA concentrations. The 
samples were then centrifuged at 16,100 g for 10 minutes at 32oC to separate the 
supernatant and the pellet. The supernatant was mixed with 4x SDS sample buffer while 
the pellet was mixed with 1X SDS sample buffer (same final SDS concentration) and both 
samples were denatured for 5 min at 95oC. Samples were run on SDS-PAGE and stained 
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with SimplyBlue SafeStain (Thermo Fisher Scientific). The protein bands of interest were 
excised and submitted to the Proteomics Resource Facility at the University of Michigan for 
protein identification using LC-MS based approach according to established protocol.  
Briefly, gel slices were destained with 30% methanol for 4 h.  Upon reduction (10 mM DTT) 
and alklylation (65 mM 2-chloroacetamide) of the cysteines, proteins were digested 
overnight with 250 ng of sequencing grade, modified trypsin (Promega).  Resulting 
peptides were resolved on a nano-capillary reverse phase column (Acclaim PepMap C18, 2 
micron, 50 cm, ThermoScientific) using 0.1% formic acid/acetonitrile gradient at 300 
nl/min (2-30% acetonitrile in 60 min followed by a 90% acetonitrile wash for 5 min and a 
further 25 min re-equilibration with 2% acetonitrile) and directly introduced in to Q 
Exactive HF mass spectrometer (Thermo Scientific, San Jose CA).  MS1 scans were acquired 
at 120K resolution.  Data-dependent high-energy C-trap dissociation MS/MS spectra were 
acquired with top speed option (3 sec) following each MS1 scan (relative CE ~28%).  
Proteins were identified by searching the data against Homo sapiens database (UniProtKB) 
using Proteome Discoverer (v2.1, Thermo Scientific).  Search parameters included MS1 
mass tolerance of 10 ppm and fragment tolerance of 0.1 Da; two missed cleavages were 
allowed; carbamidimethylation of cysteine was considered fixed modification and 
oxidation of methionine, deamidation of asparagine and glutamine were considered as 
potential modifications.  False discovery rate (FDR) was determined using target-decoy 





2.2.6 Protein identification by Western blot 
Sample preparation for Western blot was identical as described in the previous 
section. Samples were separated by SDS-PAGE and transferred to a nitrocellulose 
membrane. The membrane was washed, blocked by 5% milk, and probed using anti-actin 
antibody (Santa Cruz Biotechnology sc-8432). Three independent experiments were 
performed to confirm the obtained result. Intensity of gel bands was quantified using 
Image Studio Lite software. 
 
2.3 Results and discussion 
2.3.1 Generation of unilamellar lipid vesicles 
Double emulsion templated lipid vesicles were generated using the ultra-thin 
double emulsion device and were tested with their unilamellarity. A membrane-damaging 
protein toxin from streptococci, streptolysin O (SLO) can only insert into a unilamellar lipid 
bilayer. If the double emulsion templated lipid vesicles were unilamellar, the amount of 
fluorescence dye influx will be different when streptolysin-O was added to the lipid vesicles 
(Figure 2-7A) [103]. In a dye influx assay, as expected, the normalized fluorescence 
intensity inside the lipid vesicle compared to the outside was significantly higher when 
0.05 mg/ml streptolysin-O was introduced (Figure 2-7B), demonstrating the 
unilamellarity of the lipid vesicles generated using the double emulsion template method. 
The generation of unilamellar lipid vesicles with the capability of encapsulating 
proteins provides an important platform for constructing a simplified model of a cell for 
cell mechanics study. The properties of lipid membrane depend on the lipid compositions 
and unilamellarity of the membrane, which have been shown to affect cell stiffness. For 
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example, cholesterol depletion was shown to increase membrane stiffness of endothelial 
cells [104]. Furthermore, a lipid bilayer membrane allows the insertion of membrane 
proteins, which provides a platform to study mechanosensitive membrane channels. The 
ultra-thin double emulsion template method provides a strong foundation for further 
synthesizing a model of cell for cell mechanics study. 
 
2.3.2 Encapsulation of actin networks inside lipid vesicles 
Intracellular actin cytoskeleton is one of the major components in a cell that 
contributes to cell stiffness and mechanical properties [86]. In our simplified model of a 
cell, actin cytoskeletal components were encapsulated inside the double emulsion 
templated lipid vesicles. Actin bundles increase the bending rigidity of the actin filaments, 
and affect the elastic behaviors and deformability of the cells [65].  
Figure 2-7: Permeability test shows the unilamellarity of the lipid vesicles 
Permeability test of double emulsion templated vesicles containing 69.5% DOPC, 
30% cholesterol, and 0.5% NBD-PE formed from 36/64 chloroform/hexane in the 
middle phase. 0.05 mg/ml of SLO was incubated with the vesicles for 1 hr at room 
temperature before TMR-rhodamine was added to a final concentration of ~0.12 
mM. p < 0.05 using unpaired t test. 
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When fascin was added to the actin filaments, fascin binds and forms actin bundles 
(Figure 2-8A) [105]. This was shown experimentally in bulk solution before encapsulation 
inside the lipid vesicle (Figure 2-8B, C). When the actin monomers, fascin and actin 
polymerizing buffer were encapsulated inside the double emulsion templated lipid vesicles 
as described in Section 2.2.2 , actin bundles self-assembled inside the lipid vesicles (Figure 
2-8D).  
The intracellular actin cytoskeleton is more complicated than the actin bundles 
formed inside the lipid vesicles above. Different types of actin networks serve different 
purposes in living cells and are spatially regulated. Actin networks attach to the plasma 
membrane which together contribute to the stiffness of the cell. The encapsulation of actin 
Figure 2-8: Encapsulation of actin bundles in lipid vesicles 
(A) Schematic showing the formation of actin bundles by adding fascin to flexible 
actin filaments. (B) Actin filaments were polymerized in bulk solution. (C) Actin 
filaments and fascin were co-polymerized in bulk solution. (D) Actin and fascin were 
encapsulated inside a lipid vesicle using double emulsion template. Red color 
indicates the actin and green color indicates the lipid membrane. 
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bundles inside lipid vesicles is among one of the first few attempts to form actin networks 
inside lipid vesicles [106-110]. This represents a step towards building a simplified model 
of a cell for cell mechanics study.  
 
2.3.3 Encapsulation of mammalian cell-free expression system inside lipid vesicles 
2.3.3.1 Aggregate formed in cell-free expression encapsulated vesicles 
Besides directly reconstituting cytoskeleton networks in vesicles using 
biochemically purified proteins, we also investigated the use of cell-free expression (CFE) 
for producing proteins of interest in situ. The goal of developing mammalian CFE is to 
express a variety of proteins (including membrane proteins) in a simplified cell model. 
Since HeLa cell lysate is a highly complex and highly concentrated solution, it is essential to 
define experimental conditions within a vast parameter space where mammalian CFE is 
compatible with microfluidic double emulsion generation. As a starting point, using 
Figure 2-9: Aggregate formed in cell-free expression encapsulated vesicles 
(Left) Buffer solution (20 mM HEPES pH 7.5, 400 mM sucrose, 2% PVA, 8% PEG) 
was encapsulated as the inner phase using capillary droplet microfluidics with 
DOPC/cholesterol dissolved in chloroform/hexane as the middle phase. (Right) 
HeLa CFE (18 µl HeLa lysate, 4.5 µl Mix 1 buffer, 5.4 µl GADD34, 4.5 µl T7 RNA 
polymerase, 3.6 µl Mix 2 accessory factors and 3 µl MscL DNA plasmid containing T7 
promoter) with 2% PVA was encapsulated with DOPC/cholesterol dissolved in 




capillary droplet microfluidics, I first produced double emulsion templated vesicles at a 
high yield encapsulating 2% PVA surfactant solution (Figure 2-9, left). Recognizing that 
CFE of membrane proteins can be more facile and efficient than conventional biochemical 
purification [111, 112], I use mechanosensitive channel of large conductance (MscL) as a 
test case for membrane protein incorporation in double emulsion templated vesicles. 
Interestingly, I observed large aggregation inside double emulsion templated vesicles that 
were visible under brightfield microscopy when mammalian CFE was encapsulated 
(Figure 2-9, right). 
 
2.3.3.2 Aggregate formation was not due to insoluble membrane protein or organic solvent 
I first suspected that MscL was aggregating since membrane proteins usually 
require detergent at a concentration above critical micelle concentration (CMC) to be 
solubilized in an aqueous solution. During biochemical purification of MscL, a nonionic 
detergent Triton X-100 is typically used to solubilize MscL. Using a centrifugation assay 
(Figure 2-10A), I found that MscL produced by CFE aggregated in the absence of detergent, 
but was solubilized in the presence of 0.2% Triton X-100 (Figure 2-10B). However, using 
Triton X-100 above CMC will also solubilize lipid bilayer if it were to be used during the 
encapsulation of CFE solutions. 
To examine the possibility that the aggregate inside the vesicle was due to the 
aggregation of MscL, I examined the use of another class of surfactants made of a 
perfluorinated chain in its ability to solubilize MscL made by CFE. Fluorinated surfactants 
(FS) are amphiphilic compounds whose hydrophobic moiety consists of a perfluoroalkyl 
chain, usually linked to a polar head via a short hydrogenated spacer [113, 114]. In addition 
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to being chemically and thermally stable, perfluorinated chains are both hydrophobic and 
lipophobic, which confers peculiar properties to FS. The strong hydrophobic interactions 
among fluorinated chains of FS result in very stable self-assemblies in aqueous solutions. 
Figure 2-10: Cell-free expression of MscL is solubilized in fluorinated surfactants 
(A) Schematic illustration of the solubility assay for CFE of MscL. (B) Solubility of 
CFE of MscL after 5 hr in the presence or absence of 0.2 % of Triton X-100. (C) 
Solubility of CFE of MscL after 5 hr at different concentrations of fluorinated 
surfactant F6-TAC. (D) Formation of vesicles encapsulating mammalian CFE 
expressing MscL in the presence of 2% PVA and 0.6 mM F8-TAC. The vesicles were 
formed from 36/64 chloroform/hexane as the middle phase, and imaged in 
brightfield (top left) and in green fluorescence (top right). 5 µM of calcium indicator 
Rhod-5N and 1 mM of calcium was also encapsulated inside the vesicle (bottom 
left). Merged image of green and red fluorescence is shown in the bottom right. (E) 
Formation of HeLa lysate encapsulated vesicles formed from 40/60 
chloroform/hexane in the presence of 2% PVA and 2 mM F6-TAC, imaged in 
brightfield (left) and in fluorescence (right). 
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F6-TAC is one of the fluorinated surfactants that has been used for membrane protein cell-
free synthesis [115] or in membrane protein folding [116]. Solubility of MscL increased 
with F6-TAC concentration with almost no MscL found in the pellet at 2 mM F6-TAC 
(Figure 2-10C). 0.6 mM F6-TAC was the lowest concentration to yield soluble MscL. F8-
TAC, the same type of fluorinated surfactants as F6-TAC but with longer fluorinated chain, 
also solubilized MscL at concentration higher than 0.6 mM (data not shown). Since the 
chaperone-like activity of F8-TAC was found to be reduced at high concentration [116], 
likely due to its lower CMC value compared to F6-TAC, 2 mM F6-TAC or 0.6 mM F8-TAC 
were used in subsequent experiments without noticeable differences. 
Despite inclusion of FS in CFE when expressing MscL, aggregation was still observed 
inside the double emulsion template vesicle (Figure 2-10D). Nonetheless, MscL-eGFP was 
found to associate with the vesicle membrane and the calcium indicator dye occupied 
exclusively the lumen of the vesicle. I next wondered if the aggregates could be due to other 
CFE proteins not related to MscL expression. After overnight incubation at 32 degrees in a 
closed environment, I still found aggregates inside CFE and FS encapsulated vesicles 
without MscL, as clearly evident from the brightfield images (Figure 2-10E). These results 
suggest that components other than MscL are causing aggregations in my experimental 
system.  
I next examined the effect of middle phase solvents on the formation of aggregate 
inside CFE-containing double emulsion templated vesicle. Toluene and hexane mixtures 
with chloroform are commonly used as the middle phase solvents in the generation of 
double emulsion droplets containing diblock copolymers or phospholipids [103, 117, 118]. 
36-40% volume percent of chloroform has been shown previously to yield favorable 
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adhesion energy between the two stabilized monolayers, thus supporting dewetting and 
the formation of vesicles [118]. At higher chloroform concentrations (above 43%), double 
emulsion droplets become unstable. Since chloroform has higher water solubility than 
hexane or toluene, it will diffuse into the outer phase and evaporate. The resultant 
hexane/toluene-rich solvent is poor for phospholipid and help drive the attraction of two 
lipid monolayers in a dewetting transition [103].  
All the double emulsion droplets generated above used chloroform/hexane as the 
middle phase to dissolve the lipid mixture. Thin double emulsion droplets encapsulating 
mammalian HeLa CFE were generated using chloroform/toluene as the middle phase 
solvent. After overnight incubation at 32 degrees in a closed environment, I found 
aggregates on or inside the vesicles with a dark ring around many vesicles (Figure 2-11). 
Interestingly, some vesicles appeared to have dewetted (‘yellow’ arrows). Occasionally, I 
found vesicles extruded from the aggregates, suggesting a more solid or gel-like property of 
this aggregates. From these experiments, I concluded that the formation of aggregate was 
Figure 2-11: Aggregate was observed in the vesicle regardless of organic solvents 
Formation of HeLa lysate encapsulated vesicles formed from 40/60 
chloroform/toluene in the presence (right) or absence (left) of 2 mM F6-TAC. Yellow 
arrowheads denote the appearance of dewetted interface. 
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likely not due to the insolubility of MscL or the type of organic solvents used as the middle 
phase.  
 
2.3.3.3 Aggregate formed in the presence of 2% PVA 
I speculated the aggregates could be precipitation of proteins in cell lysates over the 
course of the experiment due to some unknown chemical reactions between the lysate and 
the surfactant used in double emulsion generation. Formation of thin shell double emulsion 
droplets consists the use of poly(vinyl alcohol) (MW: 13,000-23,000; 87-89% hydrolyzed) 
(PVA) at 2 wt% in the inner phase and 10 wt% in the outer phase [100, 103]. PVA of this 
type has been widely used as a polymeric surfactant in enhancing the stability of double 
emulsion droplets. To test whether the aggregates were a result of the PVA surfactant, I 
mixed mammalian CFE with different concentrations of PVA surfactant under bulk 
condition, which is a simple and facile approach for testing different conditions without the 
influence of middle phase organic solvents. Consistent with the findings in double emulsion 
templated vesicles, I observed macroscopic aggregates at 2% PVA (Figure 2-12A). 
However, these macroscopic aggregates did not appear when PVA concentration was lower 
than 2% (smaller aggregates were visible for 1% PVA). I further performed CFE of 
enhanced green fluorescence protein (eGFP), under bulk conditions, at different 
concentrations of PVA. Interestingly, I also observed a concentration dependent decrease of 
eGFP expression with PVA concentration. At 2% PVA concentration, I found the eGFP 
expression was reduced to ~40% compared to that without surfactant (Figure 2-12B). 
This result points to the possibility that the use of droplet stabilizing surfactant PVA plays a 
role in generating the macroscopic aggregates and reduces cell-free protein expression. 
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2.3.3.4 Pluronic surfactant also generated aggregates 
Since the surfactant PVA causes aggregation in the experimental system, I next 
examined the propensity for aggregate formation with other biocompatible surfactants. 
Another common surfactant used in emulsification process and in cell culturing is block 
copolymers of polyoxyethylene-polyoxypropylene-polyoxyethylene (PEO-PPO-PEO, also 
known as Pluronic). The hydrophilicity of Pluronic is determined by the different numbers 
of the repeating units of PEO (relatively hydrophilic) and PPO (relatively hydrophobic). 
When I used Pluronic F-68 instead of PVA as the surfactant without encapsulating HeLa 
Figure 2-12: PVA surfactant caused the formation of aggregate and reduced CFE 
activity 
(A) Brightfield images of mammalian CFE at 0, 1, or 2% of PVA surfactant. (B) eGFP 
expression in HeLa CFE as a function of PVA concentration measured in microwell 
plates (n = 3, ±S.E.), unpaired t test comparing with 0%; *: p < 0.01; **: p < 0.001. 
Brightfield images of microwell corresponding to the different PVA concentration 
are shown on top. Yellow arrowhead points to the large aggregate in the microwell. 
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lysate, I could immediately observe dewetting, as indicated by the formation of a small lipid 
reservoir, evident in both brightfield and fluorescence images (Figure 2-13A). At 2% 
surfactant concentration, the formation of aggregates was observed with three different 
Pluronic surfactants, F68, F88, and F127 (Figure 2-13B inset). Pluronic F68, F88, F127 are 
widely used in cell culture and are compatible with biological components. Pluronic F88 
and F127 had significant reduction in protein expression compared to Pluronic F68 
(Figure 2-13B). The absence of middle phase solvents in these experiments again supports 
the idea that the interaction between surfactant and mammalian CFE alone is sufficient for 
the formation of these macroscopic aggregates over time. Nonetheless, CFE could still 
Figure 2-13: Pluronic surfactant also caused the formation of aggregate and reduced 
CFE activity 
(A) Brightfield (top) and fluorescence (bottom) images of double emulsion 
templated vesicles (without HeLa lysate) with 2% Pluronic F-68. (B) eGFP 
expression in HeLa CFE at different concentrations of surfactants for Pluronic F-68 
(red), F-88 (green), and F-127 (blue), unpaired t test comparing with 0%; *: p < 
0.01; **: p < 0.001; ***: p < 0.0001. Inset shows brightfield microwell images at 2% 
of surfactant concentration with yellow arrowhead pointing to the aggregates. 
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occurred at some capacity. Although I could not observe large aggregates at 1% surfactants, 
double emulsion droplets would fail to be produced at 1% surfactant. 
 
2.3.3.5 Aggregate formed under high concentration of mammalian CFE 
Since having surfactants is important for stabilizing double emulsion droplet 
generation, I wondered if the lysate concentration could play a role in the formation of the 
aggregates. I tested this under bulk condition and used a single emulsion setup containing 
2% PVA at different HeLa lysate dilutions to simulate the encapsulated environment. Single 
emulsion setup is a quick and easy way of creating an encapsulated environment without 
the presence of volatile organic solvents. At 100% mammalian CFE concentration (11.2 ± 
1.0 mg/mL), I could find aggregates under bulk condition and in single emulsion with 2% 
PVA across different droplet sizes. Interestingly, I no longer observed aggregates when the 
CFE concentration was diluted to 40% under bulk condition or 60% in single emulsion 
(Figure 2-14A). While this result seems encouraging, I find rapidly diminishing eGFP 
expression with dilution of the entire CFE system (Figure 2-14B, left) or dilution of the 
HeLa lysate alone by varying the volume ratio between lysate and Mix 1 (Figure 2-14B, 
right).  
In support of the discovery that the high concentration of mammalian HeLa lysate in 
conjunction with surfactant led to the formation of aggregates, I find no aggregates when I 
mixed bacterial CFE system with 2% PVA (Figure 2-15A) or encapsulated bacterial CFE 
system (6.4 ± 0.9 mg/mL) using double emulsion templated vesicles (Figure 2-15B, top). 
In particular, 2% PVA has no impact on the expression of eGFP by bacterial CFE (Figure 
2-15B, bottom). This result agrees with two recent publications, in which no aggregates 
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were found when bacterial CFE system were encapsulated with 2% PVA using double 
emulsion templated vesicles [94, 95].  
Figure 2-14: High concentration of mammalian Hela lysate is prone to aggregation 
when exposed to surfactant 
(A) (Top) Representative brightfield images of different dilution of CFE reaction 
with 2% PVA under bulk condition. (Bottom) Representative brightfield images of 
single emulsions encapsulating 2% PVA at different CFE dilutions. Yellow 
arrowheads denote the appearance of aggregates. (B) (Left) eGFP expression in 
HeLa CFE as a function of CFE dilution measured in microwell plates (n = 4, ±S.E.), 
unpaired t test comparing with 1X; ***: p < 0.0001. (Right) eGFP expression in HeLa 
CFE at different volume ratios between lysate and Mix 1 measured in microwell 





2.3.3.6 Actin aggregated with PVA 
Thus far, I found that high concentration of mammalian HeLa lysate in conjunction 
with PVA surfactant led to the formation of aggregates. However, I have not identified 
component(s) that formed these aggregates. To further investigate this, the mixtures of 
mammalian CFE with different concentrations of PVA surfactant were centrifuged to 
separate the aggregate/pellet and the supernatant. While the overall amount of proteins in 
the supernatant and pellet fractions at different concentrations of PVA did not appear to 
change significantly (Figure 2-16A), I saw more protein of molecular weight around 40-45 
kDa in the pellet fraction at 1% PVA. To identify the specific protein aggregating with PVA, 
Figure 2-15: No aggregate formed in bacterial CFE 
(A) Brightfield images of bacterial CFE without (top) and with (bottom) 2% of PVA 
surfactant (B) Bacterial CFE encapsulation in double emulsion templated vesicles, 
imaged in brightfield (top left) and in lipid fluorescence (top right). (Bottom) eGFP 




the protein band was cut out and LC-tandem mass spectrometry was performed. Actin was 
identified as the major protein in the sample (mass spectrometry; 17.8% and 21.5% of 
peptides were actin at 1% and 2% PVA respectively for peptide count > 1). The aggregation 
of actin with PVA surfactant was also verified using Western blot (Figure 2-16B). The 
percentage of actin in the pellet fraction increased significantly when the mammalian CFE 
was incubated with 1% or 2% of PVA surfactant (Figure 2-16C). Interestingly, the 
percentage of actin in pellet at 2% PVA is lower than that at 1% PVA. I speculated that this 
is due to the inability of detergent to fully solubilize the proteins in the aggregate. This can 
Figure 2-16: Actin aggregates with PVA surfactant 
(A) Coomassie blue stained gel showing proteins in the supernatant or pellet after 
10 min centrifugation at 16,100 g, in the presence of PVA surfactant at different 
concentrations. (B) Western blot showing the actin in the supernatant or pellet 
fractions at different PVA concentrations. (C) Percentage of actin measured in the 
supernatant and pellet fractions at different PVA concentrations (n = 3, ±S.E.), 
unpaired t test comparing with 0% PVA; *: p < 0.01; ***: p < 0.0001. 
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also explain why I did not see a significant amount of proteins in the pellet fraction. 
Nevertheless, the results indicate that actin was one of the proteins that aggregated with 
PVA in the mammalian CFE reaction and I believe the concentrations of other proteins that 




This chapter reports the development of a simplified model of a cell for potential cell 
mechanics study. The double emulsion template was developed for the generation of lipid 
vesicles, allowing the encapsulation of actin networks or mammalian CFE system. The 
encapsulated actin bundled network was confined inside the lipid vesicles, but not 
interacting with or binding to the lipid membrane. To further create a better model of cell, 
actin binding proteins that interact with lipids can be introduced in the vesicles. 
As a yet untapped area of encapsulating mammalian CFE system as the ‘cytosol’ of 
lipid membrane-enclosed artificial cells, I reported a systematic study to examine the effect 
of PVA surfactant on mammalian CFE-containing double emulsion templated vesicles. 
Although I found 2% PVA surfactant reduces protein expression and led to the formation of 
macroscopic aggregates in mammalian HeLa CFE, 2% PVA surfactant is critical for stable 
microfluidic double emulsion generation. I showed that the high protein concentration in 
HeLa CFE and PVA surfactant present a condition for these aggregates to form. I further 
discovered that even when the macroscopic aggregates only appeared when the 
concentration of PVA surfactant reached 2%, actin is one of the proteins in the mammalian 
CFE that aggregated with PVA. With the hydrophobic and hydrophilic parts of the PVA 
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surfactant, it is not surprising to see that proteins important for cell-free synthesis could 
also be aggregating with PVA. My work thus provides a baseline description of the current 
state-of-the-art in encapsulation of mammalian CFE system in double emulsion templated 
vesicles and offer directions for further improvement and optimization for the building of a 
simplified model of a cell.  
Overall, our simplified model of a cell with actin bundled network or mammalian 
CFE is a step towards building artificial cell with the functions and properties of cells, so 




Chapter 3: Prototyping a microfluidic compression 
device for mechanically activating artificial cell 
 
* This chapter has been published in Ho et al., Scientific Reports, 2016. 
 
3.1 Introduction 
3.1.1 Engineering artificial cell 
Engineering artificial cell to mimic one or multiple functions of a cell is an emerging 
area of synthetic biology. Engineering artificial cells is a high-risk, high-reward path 
towards the advancement of both basic and applied science. Venter and coworkers have 
spent more than 15 years until they finally succeeded in designing and chemically 
synthesizing a minimal bacterial genome for transplantation into a host bacterium, thereby 
producing a minimal autonomously replicating cell [119]. The synthesis of minimal self-
replicating cells helps to answer many basic scientific questions about the minimum 
genome to support life and also opens up new applications, such as novel vaccine 
development and sustainable bio-fuels. 
Bottom-up in vitro reconstitution is an alternative approach in engineering artificial 
cells by which cellular functions are reconstituted by component macromolecules to study 
cellular assembly and organization [16]. While cell biology has generated a wealth of 
knowledge about cellular pathways and processes, a purely top-down approach cannot 
provide complete understanding into how mixtures of macromolecules assemble and 
organize dynamically into spatially complex structures or generate emergent behaviors. 
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Bottom-up reconstitution offers a way to peel away cellular complexity through building 
from cellular components [120], and building bio-inspired artificial cells where inherent 
complexities of living cells are stripped away holds tremendous promise in a broad range 
of applications [121]. Kurihara et al. built a protocell that responds to external 
environmental stimuli and demonstrated self-proliferation over multiple generations 
[122]. This work illustrates how assembly of well-defined lipids and macromolecules could 
emerge into a collaborative and dynamic system. Engineering artificial cells can also 
advance applied science in other creative ways. For example, Lentini et al. engineered an 
artificial cell to translate unrecognized signals into chemical language that E. coli can 
recognize to expand the sensory capacities of E. coli without changing their genetic content 
[123]. 
 
3.1.2 Challenges in synthesizing cell-like artificial cells 
Bottom-up synthesis of cell-like artificial cells faces two general challenges – 
encapsulation and stability. With advances in droplet microfluidics, artificial cells can now 
be generated in a high-throughput manner with high encapsulation efficiency. As a chassis 
of artificial cells, droplet microfluidics has been used to aid the synthesis of liposomes by 
double emulsion template [103], layer-by-layer assembly [124, 125] and microfluidic 
jetting [126, 127]. As a promising approach towards building artificial cells, cell-free 
expression components were encapsulated within a lipid bilayer platform by droplet 
microfluidics [94, 100, 128]. However, building artificial cell systems directly with lipid 
bilayer has challenged many research groups, mainly due to low stability of artificial cells. 
Encapsulation of complex solutions (e.g. cell free expression system) poses unique 
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challenges that could stem from the chemistry of current droplet microfluidics approaches 
for making lipid bilayer vesicles [129]. Furthermore, without cytoskeleton networks that 
exist in all natural cells to provide mechanical support and adaptation to surrounding 
environment, liposomes with sizes comparable to natural cells (~10 µm) are vulnerable to 
environment challenges, for example, osmotic shock. These difficulties have motivated me 
to use double emulsion droplets (aqueous/oil/aqueous) as an alternative model system to 
prototype artificial cells. Indeed, numerous studies have used single or double emulsions or 
other compartmentalized schemes as artificial cells [130, 131].  
 
3.1.3 Microfluidics: tool for mechanically activating artificial cells 
Current engineered artificial cells have been limited to sensing chemical inputs or 
physicochemical properties of membrane [123, 132, 133], while the idea of engineering a 
mechanosensing artificial cell has never been conceived. Mechanical forces are arguably 
the most primitive signal and mechanosensation is universal to all living organisms [134]. 
In principle, a mechanosensing artificial cell could be engineered to sense and respond to 
mechanical forces, such as shear, tensile, or compression forces. To demonstrate the 
construction of mechanosensing artificial cell, a precisely controlled platform is required to 
physically apply mechanical forces to artificial cells. Microfluidics provides a platform with 
precise microenvironment control and it has been utilized in numerous applications in 
synthetic biology, ranging from automated DNA assembly [135, 136], automated genetic 
engineering [137], to precise control of bacterial culture [138]. Microfluidic technology and 
synthetic biology have also been combined together for studying different genetic circuit 
systems, such as metabolic gene network [139], synchronizing genetic oscillations [140, 
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141] and molecular clocks [142]. Recently, microfluidics was used to engineer on-chip 
artificial cells [131, 143]. The growth of microfluidics in synthetic biology applications is 
clearly evident. In the context of the present study, microfluidics can provide precise 
mechanical input to artificial cells. Microfluidics technology has been widely adopted in 
single cell mechanobiology studies where the effect of different modes of mechanical forces 
on cellular functions have been investigated [43-46, 83, 84]. Thus, the capability and 
controllability of microfluidics offer a versatile platform for engineering and studying 
mechanically activated artificial cells. 
As a first step, I developed a multilayer microfluidic platform to trap and apply 
mechanical forces to single artificial cells. I used double emulsions generated from droplet 
microfluidics as a model of artificial cell similar to what was described in Chapter 2. The 
novel microfluidic device could compress or aspirate on double emulsion droplets to 
increase or decrease the thickness of oil in the middle phase, respectively. By thinning the 
oil phase, I demonstrated the influx of calcium ions as a biological response of the 
mechanically activated artificial cell. The influx of extracellular calcium ions is one of the 
most important signaling pathways found in living cells, where calcium ions serve as 
secondary signaling messengers and exert regulatory effects on different enzymes and 
proteins. The study here combining microfluidics and artificial cells opens up new 
possibilities in the development of force-activated synthetic biology. 
 
3.2 Model of mechanosensing artificial cell 
In biological systems, selectively permeable membrane is composed of a thin single 
bilayer of lipid molecules with a thickness of ~5 nm. Membrane proteins such as 
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transporters and ion channels are important in controlling transport of chemicals and ions 
across the membrane. Mechanosensitive channels that are responsive to membrane 
tension are found from bacteria (e.g. MscL) to mammalian cells (e.g. Piezo 1) [144, 145]. 
Reconstituting mechanosensitive channel activity as a path towards constructing 
mechanosensitive artificial cell is a challenging, yet promising approach. As an alternative 
model to lipid bilayer vesicles, double emulsion droplets can be used to prototype artificial 
cells (Figure 3-1A). As water and oil are immiscible with each other, the middle oil phase 
separates the inner and outer aqueous phase to form double emulsion. The thickness of the 
oil dictates the transport of hydrophobic solute via diffusion [146] or by reverse micelles in 
the presence of osmotic mismatch [147]. To prototype mechanosensing artificial cells, I 
Figure 3-1: Prototyping mechanosensing artificial cells 
(A) Lipid bilayer partitions the internal environment of a cell where ions do not 
cross. Double emulsion can serve as a model of an artificial cell where the oil middle 
phase can vary in thickness and acts as a semipermeable barrier for ions to pass 
through. (B) A microfluidic device can be utilized to compress or aspirate on double 
emulsions as a way to alter oil thickness and mechanically activate artificial cells. 
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investigated the possibility of using compression and aspiration to alter oil thickness in 
double emulsion as a mechanism to mechanically activate artificial cells (Figure 3-1B). 
 
3.3 Microfluidic device overview and design 
To demonstrate the construction of mechanosensing artificial cells, a microfluidic 
device is designed to trap double emulsions into trapping chambers, and apply 
compression and aspiration to them in a parallel manner. The device, made out of 
polydimethylsiloxane (PDMS), has two layers, the flow layer and the control layer (Figure 
3-2). The flow layer (blue) has a similar design as the previously reported microfluidic 
pipette array (µFPA) device in the lab [46] where fluid and double emulsions flow from one 
inlet through the microfluidic channel to one outlet. The microfluidic channel first splits 
into two channels, each containing 7 trapping chambers. Each trapping chamber is 
connected to the opposing end of the main microfluidic channel through a small 
microchannel, akin to a micropipette that can perform aspiration. The flow layer is 
designed such that the flow resistance of the small microchannel is 20 times larger than 
that of the main microfluidic channel. Thus, flow is directed primarily through the main 
microfluidic channel and not through the trapping chambers. A thin PDMS membrane 
separates the microfluidic channel and the control layers (pink and orange) that serve two 
different functions and are independently controlled (Figure 3-2B). To direct flow to the 
trapping chambers, a pneumatically controlled valve set located above the microfluidic 
channel blocks the flow in the main microfluidic channel when the valve set (Control valve 
set 1, pink) is actuated. A second control valve set (Control valve set 2, orange) directly 
above the trapping chambers exerts compression to trapped double emulsion when the 
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valve set is actuated. Since the two control valve sets can be independently controlled, 
trapping is decoupled from compression. 
 
Figure 3-2: Overview and design of the microfluidic device 
(A) The design of the microfluidic device is shown. The device has two PDMS layers 
that consist of a deformable microfluidic channel and two independent control valve 
sets. (B) Close-up view of the control valve sets from the dotted box in (A). Control 
valve set 1 facilitates the trapping of droplets inside the trapping chambers and 
Control valve set 2 provides in-plane compression of the trapped droplets. (C) Top 
view (top) and side view (bottom) of a trapping chamber. The microfluidic channel 
is beneath the control layer and is separated by a thin, deformable PDMS membrane. 
The pipette structure adjacent to the trapping chamber locates at the bottom of the 
microfluidic channel. (D) A picture of the actual device connected with micro-
tubings: blue and red color dyes label the microfluidic channel and control valve 
sets respectively, scale bar = 3 mm. 
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3.4 Materials and methods 
3.4.1 Glass capillary microfluidic device 
Glass capillary microfluidic device used in this chapter has a different design 
comparing to the one described in Chapter 2 to generate double emulsions with thicker 
middle phase. The device was fabricated by assembling tapered round capillary, square 
capillary and syringe needles together using 5 minutes epoxy (Figure 3-3) [98]. First, the 
round glass capillary (Sutter Instrument B100-58-10) was pulled using a pipette puller 
(Sutter Instruments P-87).  The tapered capillary was then sanded using 1200 grade 
sandpaper to obtain a 100 µm opening for the collection tube. The outside surface of a 
clean 15 µm opening injection tube, pulled and similarly sanded, was treated with 
trichloro(1H,1H,2H,2H-perfluorooctyl)silane to render the surface hydrophobic. Then, the 
injection tube and collection tube were inserted into a square capillary (AIT, 810-9917) 
placed on a glass slide and they were aligned under an optical microscope. Syringe needles 
(McMaster Carr, 75165A677) were cut and glued to the glass slide using 5 minutes epoxy 
(Devcon, 14250). Lastly, micro-tubings (Scientific Commodities, BB31695-PE/5) were 
connected to the syringe needles. 
Figure 3-3: Glass capillary microfluidic device for formation of double emulsions 
The glass capillary microfluidic device is fabricated by aligning two tapered round 
capillaries inside a square capillary. Monodisperse double emulsion droplets form 
when the inner aqueous phase, middle oil phase and outer aqueous phase are 
pumped into the device in the corresponding compartments. 
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3.4.2 Double emulsions generation 
For a stable double emulsion system, I used fluorinated oil (HFE-7500, RAN 
Biotechnologies) with fluorosurfactants, which was synthesized by coupling oligomeric 
perfluorinated polyethers (PFPE) with polyethyleneglycol (PEG) [148], as the middle 
phase. Monodisperse double emulsions were generated using the glass capillary 
microfluidic device described in the previous section. The inner aqueous phase contained 
20 µM rhodamine succinimidyl dye (Fisher scientific, 50-851-056) or 100 µM Rhod-2 
(Thermo Fisher Scientific, R-14220), 800 mM glucose, 20 mM HEPES pH7.5, 250 µM EGTA. 
The middle oil phase contained 2 wt% 008-FluoroSurfactant in HFE7500. The outer 
aqueous phase contained 10 wt% Poly(vinyl alcohol) (PVA) (Sigma, MW 13,000-23,000, 
87-89% hydrolyzed) or 8 wt% PVA, 300 mM CaCl2, 20mM HEPES pH7.5, 250 µM EGTA. The 
three phases were pumped into the glass capillary microfluidic device using three OEM 
syringe pumps (New Era Pump Systems, NE-500). For the 65 µm double emulsion that had 
an oil thickness of 11 µm, the flow rate used for the inner, middle and outer phases were 
450, 700, 6000 µl/hr respectively. The flow rate of the middle phase and outer phase were 
set at 400 and 8000 µl/hr for a thinner and smaller double emulsion; and at 900 and 5000 
µl/hr for a thicker and larger double emulsion. 
 
3.4.3 Device fabrication 
The microfluidic device was fabricated using multilayer polydimethylsiloxane 
(PDMS) soft-lithography technique [149]. The microfluidic device is composed of a PDMS 
control layer and a PDMS flow layer, which were aligned and bonded permanently onto a 
PDMS coated microscope glass slide.  
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Three photomasks were produced by high resolution inkjet printing on 
transparency film (CAD/Art Services) for SU-8 patterning of two silicon molds by standard 
photolithography. The first silicon mold is composed of one layer of SU-8 pattern for PDMS 
casting of the control layer. The SU-8 pattern of the control layer defined two sets of 
integrated microfluidic control valves for closing of the main microfluidic channel (Control 
valve set 1) and deflections of the flow layer in the trapping chambers for planer 
compression of double emulsions (Control valve set 2) respectively. These two sets of 
microfluidic control valves contained two independent inlets. The other silicon mold is 
composed of two layers of SU-8 patterns to be used for PDMS spin-coating of the flow layer. 
The first SU-8 patterning layer defined the side microfluidic pipette channel for aspiration. 
The second SU-8 patterning defined the main microfluidic channel, the trapping chambers, 
and a single pair of inlet and outlet.  
The SU-8 patterning procedures of the two silicon molds followed the standard 
protocol developed by Microchem, Inc. for SU-8 2000 [150]. First, two silicon wafers were 
dehydrated on a hotplate at 200oC for 15 min to promote photoresist adhesion. In SU-8 
patterning the silicon mold for the control layer, SU-8 2025 was spin-coated at 1500 rpm 
onto the wafer for 30 s, which gave a thickness of 45 µm. The photoresist was then exposed 
to UV light for 20 s under a contact aligner (Karl Suss, MJB45). In the first SU-8 patterning 
of the flow layer, SU-8 2010 was spin-coated at 1500 rpm onto the silicon wafer for 30 s, 
which gave a thickness of 16 µm. The photoresist was then exposed to UV light for 15 s 
with the first flow channel photomask, which defined the side pipette arrays. After 
development of first SU-8 layer, the silicon wafer was hard-baked at 200oC for 20-30 
minutes to consolidate the developed SU-8 patterns before the application of the second 
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SU-8 layer. Subsequently, for the second layer SU-8 patterning of the flow layer, SU-8 2025 
was spin-coated at 1500 rpm onto the silicon wafer for 30 s, which gave a combined 
thickness of 60 µm. The photoresist was then aligned with the second flow channel 
photomask, which mainly defined the main microfluidic channel, and exposed to UV light 
for 20 s. After development of SU-8, both silicon molds were hard-baked at 200oC for 20-30 
minutes again to cure any surface cracks. The thicknesses of both the control layer and flow 
channel SU-8 pattern were measured using a stylus profilometer (Dektak 6M). 
Before PDMS casting or spin-coating on the silicon molds, both wafers were first 
silanized with trichloro(1H,1H,2H,2H-perfluorooctyl)silane (Sigma-Aldrich) in a desiccator 
for 1 hour. The silicon mold for the control layer was casted with PDMS (Sylgard-184) with 
a mixing ratio of 7:1 (base:curing agent). After degassing in a desiccator, the control layer 
PDMS substrate was then cured at 60oC overnight before demolding from the wafer. The 
PDMS substrate was then diced and holes were punched with 1 mm diameter at the inlets 
of the microfluidic control valves. The flow channel membrane was generated by spin-
coating PDMS with a mixing ratio of 20:1 (base:curing agent) on the flow layer silicon mold 
at rotational speeds between 1000 to 1600 rpm for 30 s. After this, the PDMS flow layer 
membrane was cured at 60oC for 2 hours. Both the diced PDMS control substrate and the 
PDMS flow layer membrane on the silicon mold were placed in an oxygen plasma etcher 
(Femto, Covance) to render the PDMS surfaces hydrophilic for the preparation of bonding 
procedure described as follows. The flow layer silicon mold containing the PDMS 
membrane was mounted on a customized alignment platform on an optical microscope. 
The diced PDMS control layer substrate was then careful aligned and bonded with the 
PDMS flow layer membrane. The permanent bonding between the control layer substrate 
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and PDMS flow layer membrane was established by heating in the furnace at 60oC 
overnight with the aid of gentle pressing between two substrates. The day after, the 
bonded control layer substrate with the flow layer membrane was then cut out and peeled 
off from the flow layer silicon wafer. Inlet and outlet holes (1 mm diameter) for the main 
microfluidic flow channel were punched through the layer PDMS control/flow substrate. 
Finally, the PDMS substrate was bonded to a PDMS-coated microscope glass slide following 
the procedures of two-hour PDMS curing and oxygen plasma treatment as described 
previously. Schematic of the fabrication process flow of the microfluidic device can be 
found in Figure 3-4. 
 
3.4.4 Imaging membrane deflection and 3D image reconstruction 
The microfluidic device was mounted on a spinning disk confocal microscope 
(Olympus IX73 with Yokogawa CSU-X1) for image acquisition using a 20X objective. Four 
different micro-tubings were connected to the microfluidic device. The control layer inlets 
of the microfluidic device were connected through 4-way stopcock switches (Nordson, FC 
series) to a compressed air source with a pressure regulator (Norgren). Rhodamine 
succinimidyl dye (Fisher scientific, 50-851-056) was flowed into the device through the 
inlet of the flow channel using a syringe pump. By setting the position of the stopcock 
switches, compressed air of pressure ranging from 0 psi to 30 psi was applied to deflect the 
PDMS membrane above the trapping chambers. A z-series of fluorescence images, excited 
at 561 nm, was captured at a step size of 1 µm and was reconstructed in ImageJ to generate 





Figure 3-4: Fabrication process of microfluidic device 
The silicon mold for control layer and flow channel were casted with PDMS of 
different mixing ratio. The PDMS substrate of the control layer was aligned with the 
flow channel membrane and bonded together. Finally, the PDMS control/flow 
substrate was peeled off from the flow layer silicon wafer and bonded to a PDMS-
coated microscope glass slide to form the final microfluidic device. 
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3.4.5 Imaging double emulsions trapping, compression and aspiration 
The microfluidic device was mounted on an optical fluorescent microscope (Nikon, 
Ti Eclipse) for image acquisition using a 10X objective. The control layer inlets were 
connected to a compressed air source. Double emulsions were first formed as described in 
the glass capillary microfluidic device, encapsulating 20 µM rhodamine succinimidyl dye, 
and then flowed into the microfluidic device using a syringe pump at 10X dilution at 10 
µl/min. For trapping double emulsions, once they reached the flow channel, the flow rate 
was reduced to 0.2-0.5 µl/min and 10-15 psi pressure was applied to Control valve set 1, 
which blocks the flow through the main microfluidic channel. Control valve set 1 was 
decompressed after the double emulsions were trapped in the trapping chambers, typically 
in under a minute. For double emulsion compression, the stopcock switches were then 
configured to apply compressed air to Control valve set 2. The applied air pressure varied 
from 0 to 30 psi. For double emulsion aspiration, no air pressure was applied to neither of 
the control valve sets. The pressure difference across the double emulsions were controlled 
by varying the flow rate in the flow channel. 
 
3.4.6 Flow simulation 
The fluid flow in the flow channel of the microfluidic device was simulated using 
COMSOL 4.4 (COMSOL Multiphysics). The three dimensional model of the device was 
constructed in Solidworks with the height of the micropipettes and main microfluidic 
channel as measured from the flow channel SU-8 pattern. The pressure differences across 
trapping chambers were simulated using the laminar flow module. The problem is 
computed as incompressible flow. Water was chosen as the fluid material of the entire 
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domain. No-slip boundary conditions were used on all the walls except the inlet and outlet. 
The inlet was set as normal inflow velocity, which was calculated from the flow rates and 
cross-sectional area of the inlet. A zero constant pressure with backflow suppression was 
used at the outlet. 
 
3.4.7 Hypo-osmotic shock experiment for calcium transport 
Double emulsions were generated as described in the glass capillary microfluidic 
device, with 100 µM calcium indicator Rhod-2, 800 mM glucose, 20 mM HEPES pH7.5, 250 
µM EGTA as the inner phase and 8 wt% PVA, 300 mM CaCl2, 20mM HEPES pH7.5, 250 µM 
EGTA as the outer phase. The osmolarity of the inner and outer phase were measured using 
a Vapor Pressure Osmometer (ELITechGroup, 5600) and were balanced. The microfluidic 
device was mounted on an optical fluorescent microscope with a 10X objective and the 
control layer was connected to the pressure regulator as described before. The flow 
channel inlet was connected to two syringe pumps using a T-junction connector. Two 
syringes with double emulsion solution and a hypo-osmotic solution (8 wt% PVA, 200 mM 
CaCl2, 20mM HEPES pH7.5, 250 µM EGTA) were connected to the two syringe pumps 
respectively. First, the double emulsions were pumped into the device and trapped inside 
the trapping chambers. Then, the outer phase was changed to the hypo-osmotic solution. 
The trapped double emulsions were aspirated and thinned out by increasing the flow rate 
of the hypo-osmotic solution. The fluorescence of the inner phase was monitored at a time 




3.5 Results and discussion 
3.5.1 Membrane deflection and compression by pneumatic control.  
One of the features that the microfluidic device has is to compress trapped double 
emulsions in the trapping chambers. Control valve set 2 features rectangular patterns 
above each trapping chamber. When Control valve set 2 is pressurized, the PDMS 
membrane above the trapping chambers deflects and compresses the double emulsions 
trapped in the trapping chambers. The rectangular patterns of Control valve set 2 needs to 
be aligned with the trapping chambers of the microfluidic channel (Figure 3-5A) such that 
deflection of the PDMS membrane is directly over the trapping chambers. Without 
actuation, the membrane remains flat. When air pressure in Control valve set 2 increases 
and is higher than the liquid pressure in the microfluidic channel, the PDMS membrane 
deflects towards the flow channel (Figure 3-5B). The deflection of the membrane is 
dependent on the material property of the PDMS membrane, the thickness of the 
membrane and the applied pressure in Control valve set 2. To fabricate PDMS membrane 
with a higher elasticity for better deflection compared to PDMS with 10:1 (base:curing 
agent) mixing ratio [152], I chose a higher mixing ratio of 20:1 to make the PDMS 
membrane. By varying the PDMS spin-coating speed on the flow layer silicon mold (1000 - 
1600 rpm), I can generate PDMS membrane with thicknesses ranging from 20 µm to 44 µm. 
To examine the deflections of membrane with different thicknesses as a function of 
different applied pressures, I labeled the microfluidic channel volume with rhodamine 
succinimidyl dye since I cannot directly label the PDMS membrane. When Control valve set 
2 is pressurized, the membrane deflects and displaces the fluid in the microfluidic channel 
so that I can indirectly visualize membrane deflection. The reconstructed 3D and side view 
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images of the compressed trapping chamber showed the increase in membrane deflection 
with increasing applied pressure (Figure 3-5C). Importantly, the PDMS membrane 
contacts the bottom of the flow channel at 30, 25 and 20 psi for devices with PDMS spin-
coating speeds of 1000, 1200 and 1600 rpm respectively. By quantifying the deflection of 
the membrane, I found that the deflection percentage is linear with the applied pressure for 
a given PDMS membrane thickness (Figure 3-5D). When the PDMS membrane thickness is 
reduced by increasing spin-coating speed, I found a larger deflection at the same applied 
pressure. Both of these results agree with a mechanical intuition of plate deflection.  
Figure 3-5: Deflection characterization of PDMS membrane by pressurizing control 
layer 2 
(A) Top view: Control valve set 2 is aligned with the trapping chambers in 
microfluidic channel. (B) Side view: Air pressure in Control valve set 2 is regulated 
by a pressure regulator. At zero pressure, the membrane between Control valve set 
2 and microfluidic channel is flat. When Control valve set 2 is pressurized, the 
membrane deflects. (C) Images from confocal microscopy of fluorescent dye 
perfused in the microfluidic channel. Z-stack images were reconstructed in ImageJ 
to generate 3D and side view images. The deflections of PDMS membrane with 
different spin-coating speed under different applied pressure are shown, scale bar = 
50 µm. (D) The percent deflection of the PDMS membrane as a function of different 
PDMS spin-coating speed and applied pressure (n = 4). The PDMS membrane 
thickness t (mean ± SEM) was measured for each spin-coating speed. 
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To identify the ideal spinning speed and membrane thickness for the microfluidic 
device, I considered two criteria, which were the strength of PDMS bonding and the 
strength of the membrane from rupturing. Although the PDMS substrates were oxygen-
plasma treated before being bonded together, a high enough air pressure could break the 
PDMS bonding, leading to a blockage of the microfluidic channel. Therefore, a thinner 
membrane was preferable under this consideration because thinner PDMS membrane 
completely blocked the microfluidic channel at a lower applied pressure. However, when 
the PDMS membrane was too thin, the device fabrication process became more challenging 
due to bonding issues. Based on these considerations, I fabricated and worked with 
microfluidic devices with a 1200 rpm PDMS spinning speed on the flow layer silicon mold, 
from which the membrane deflects and completely blocks the flow channel at 25 psi. 
 
3.5.2 Trapping of double emulsions 
Double emulsions were trapped inside the microfluidic device for the application of 
mechanical forces. Double emulsions with a diameter between 40 µm and 90 µm were first 
generated in a glass capillary microfluidic device (Figure 3-3) and then reinjected into the 
microfluidic device at 10x dilution. To trap double emulsions in the trapping chambers, 
Control valve set 1 was then pressurized at 10-15 psi to block the main microfluidic 
channel, which increased the flow resistance in the main microfluidic channel. As a result, 
the flow resistance ratio between the microchannels and the main microfluidic channel will 
reduce and more fluid streamline will go through the microchannels. This greatly increases 
the trapping efficiency of the double emulsions and I typically find all 14 trapping 
chambers filled up within a minute. A double emulsion will be trapped if the radius of the 
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double emulsion is smaller than the instantaneous critical stream width, which is dictated 
by flow resistance ratio between the micropipettes and main microfluidic channel [153]. 
Therefore, a double emulsion with larger diameter is usually more difficult to trap; 
however, with actuation of Control valve set 1, the microfluidic device successfully trapped 
double emulsions of 46, 68 and 90 µm in diameter, as shown in Figure 3-6A.  
 
3.5.3 Reversible compression of double emulsions 
After demonstrated successful trapping of double emulsions, I next evaluated the 
effect of compression on double emulsions. Control valve set 2 was designed to compress 
double emulsions inside the trapping chambers. Due to the fluid properties of the inner 
aqueous and middle oil phases, double emulsions deform easily when they experience 
different external flow fields [154, 155]. But when the external load is removed, double 
emulsions return to their original spherical shapes due to interfacial tension. When I 
increased the applied pressure in Control valve set 2 and compressed the trapped double 
emulsions, the middle oil phase in-plane thickness increased. Double emulsions of 50 and 
80 µm in diameter were compressed using an air pressure up to 20 and 15 psi respectively 
(Figure 3-6B). At 20 psi air pressure, the 80 µm double emulsions escaped from the 
trapping chambers due to the confined space inside the trapping chambers and their larger 
sizes. For both sized double emulsions, compression changed their shape and oil thickness. 
Figure 3-6C shows the increase in average in-plane thickness of the middle oil phase with 
increasing applied pressure. The double emulsions with outer diameter of 50 µm had a 3.8 
fold increase in middle phase thickness, while a 2.3 fold increase was observed for 80 µm 
double emulsions. The change in average in-plane thickness of the middle oil phase was 
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completely reversible when pressure was reduced back to 0 psi after compression (Figure 
3-6D). Together these results showed the capability of the microfluidic device to compress 
double emulsions to increase their middle oil phase thickness. 
Figure 3-6: Trapping and compression of double emulsions inside trapping 
chambers 
(A) Double emulsions of different sizes were trapped in the trapping chambers, 
scale bar = 50 µm. (B) Double emulsions trapped inside trapping chambers were 
deformed at different applied air pressures on Control valve set 2. The double 
emulsion droplets were squashed upon compression and returned back to spherical 
shape after compression. (C) The changes in average in-plane thickness of the 
middle oil phase as a function of applied pressure for two different sized droplets (n 
= 3, mean ± SEM). Average in-plane thickness is calculated by averaging the largest 
thickness and the smallest thickness of the double emulsion. (D) The average in-
plane thickness of the middle oil phase for two different sized droplets before and 
after compression (n = 3, mean ± SEM). 
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3.5.4 Oil removal by aspiration of double emulsions 
Double emulsions are very stable and oil must be removed in order to thin out the 
oil phase. I postulated that aspiration of the middle oil phase could result in permanent 
thinning of the oil phase. Aspiration is achieved with the same mechanism used in µFPA 
device previously [46]. The pressure difference across the microchannel comes from the 
pressure drop through the main microfluidic channel due to fluid flow (Figure 3-7A), 
which is the product of the volume flow rate and flow resistance of the main microfluidic 
channel. To determine the relationship between flow rate and pressure difference for each 
trapping chamber for the relatively complex microfluidic channel design, I performed flow 
simulation of the flow channel using COMSOL. As shown in Figure 3-7B, the pressure 
difference is linear with the flow rate for each trapping chamber, with the largest pressure 
difference for the most upstream trapping chamber.  
To test the effect of aspiration on double emulsions, I encapsulated rhodamine 
succinimidyl dye in 80 µm double emulsions that had an average in-plane oil thickness of 
8.2 µm. By increasing the flow rate, I aspirated on double emulsions and observed several 
behaviors through dynamic changes of aspiration pressure, as shown in Figure 3-7C. At 
low aspiration pressures of 8.5 or 21.3 Pa, oil was aspirated into the micropipette. 
Interestingly, when the pressure difference increased from 34.6 to 69.3 Pa, oil began to 
pinch off and the middle phase thinned out over several seconds. The transition of oil 
aspiration to pinching off occurs when the protrusion length of the double emulsion is 
larger than the hydraulic radius of the aspiration micropipette. After applying a high 
pressure difference to the double emulsions for several seconds (69.3 Pa, >5.8 s), the oil in 
the double emulsion became nearly invisible by bright field imaging. However, there is 
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some residual oil remained inside the micropipette channel. When the pressure difference 
was reduced back to 34.6 Pa, the oil retracted from the micropipette channel and refilled 
the double emulsion middle phase (34.6 Pa, 1.5 s). The double emulsion remained stably 
trapped after thinning of the oil phase, as evident by the intact encapsulated fluorescent 
dye in the aqueous inner phase. The average in-plane thickness of the middle oil phase of 
this single double emulsion was measured at aspiration pressure differences of 69.3 and 
Figure 3-7: Thinning of the middle phase in double emulsion droplets by aspiration 
(A) The flow layer microfluidic channel is designed such that trapped droplets in the 
trapping chambers experience a pressure difference induced by fluid flow in the 
microfluidic channel. (B) The relationship between flow rate and pressure 
difference at different trapping chamber position was obtained from COMSOL 
simulation. (C) A double emulsion droplet trapped in the trapping chamber was 
aspirated by changing the pressure difference. As the pressure difference increased, 
the oil changed from being aspirated to pinching off and thinning out. When the 
pressure difference was reduced, the oil retracted. After the thinning of oil, the 
double emulsion remained inside the trapping cup and the initially encapsulated 
fluorescent dye remained in the double emulsion. (D) The change in average in-
plane thickness of the middle oil phase with respect to time for the same double 
emulsion shown in (C) at a pressure difference of 69.3 and 34.3 Pa. 
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34.6 Pa (Figure 3-7D). This experiment demonstrated that the middle oil phase can be 
thinned out permanently by aspiration in the microfluidic device.  
 
3.5.5 Mechanically activated double emulsion through aspiration and osmotic shock 
facilitates calcium transport through oil 
Through compression and aspiration, the microfluidic device enables temporary 
thickening and permanent thinning of the middle oil phase in double emulsions. The 
middle oil phase in a double emulsion behaves like a semi-permeable membrane through 
which solute molecules can diffuse into and out of the inner aqueous phase. This is 
especially relevant in drug delivery application, where non-ionized hydrophobic drug 
diffuses through the oil obeying Fick’s law of diffusion. Since ions are hydrophilic, they 
cannot diffuse through oil easily. However, in the presence of an osmotic pressure 
difference during hypo-osmotic shock, it has been observed that ions can also transport 
along with water through Span80 stabilized oil phase of double emulsions via two different 
mechanisms [156]. When there is no contact between the two interfaces, reverse micelles 
form by lipophilic surfactant molecules and diffuse through the oil, while transport of 
water is carried by single hydrated surfactant molecules when there is contact between the 
two interfaces [156-158]. The ion transport was also found to be dependent on the oil-
soluble surfactant [156]. Fluorinated oil (HFE-7500) with fluorosurfactants (PFPE-PEG) 
used to generate double emulsions in this study has been shown to provide permeability to 
oxygen and other non-ionized small molecules [159, 160]. However, the transport of ions 
through this oil is not known. Thus, I investigated ion transport through the middle oil 
phase as a biological response that involves mechanically perturbing double emulsions. 
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In order to detect transport of calcium ions during osmotic downshock, I 
encapsulated Rhod-2 calcium indicator in double emulsions (Figure 3-8A). I did not find a 
significant change in fluorescence when I subject thick double emulsions with hypo-
Figure 3-8: Mechanically activated artificial cell through aspiration and osmotic 
shock facilitates calcium ion transport through oil 
(A) Thick double emulsions are aspirated in the microfluidic pipette array and 
compression (µFPAnC) device to form thinner double emulsions. Both thick and thin 
double emulsions are hypo-osmotically shocked, such that calcium ions diffuse 
through the oil and enter the double emulsions. (B) The changes in fluorescence 
level as a function of time for thick double emulsions (Thickness = mean ± S.E.: t = 
10.7 ± 0.1 µm) in iso- and hypo-osmotic solution. (n = 10). (C) The changes in 




osmotic shock (Figure 3-8B). However, when I aspirated the double emulsions to 
permanently thin out the oil, calcium ions entered the double emulsions rapidly as 
indicated by the increase in fluorescence for the calcium indicator (Figure 3-8C). By 
comparison, unaspirated double emulsions that had a thicker middle phase did not have 
increased fluorescence during osmotic downshock over the same period. This indicates 
that by aspirating double emulsions using the microfluidic device, calcium ions in the outer 
phase entered the double emulsions faster. The transport of ions through the fluorinated 
oil of this emulsion system behaved differently when compared to that through hexadecane 
with Span80 [156]. Nevertheless, I demonstrated mechanical activation of double emulsion 
artificial cell with influx of calcium ions.  
 
3.6 Conclusions 
In this work, I have developed a microfluidic device, which combines microvalves 
with the previously developed µFPA device in the lab to uncouple trapping from aspiration 
and to exert compression. The device contains a flow channel for aspiration and a control 
layer for trapping and compression. By connecting a syringe pump to the flow channel and 
a regulated pressurized air to the control layer, the device is able to trap artificial cells in 
designated compression and aspiration chambers with high trapping efficiency and exert 
compression and aspiration. 
I successfully demonstrated mechanically activated artificial cell using this newly 
designed microfluidic device. The prototype of artificial cell is a double emulsion with oil 
separating the inner and outer aqueous phases. I showed that I can regulate oil thickness 
by compression and aspiration as a way to mechanically regulate transport process in 
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artificial cells. This represents the first demonstration to couple a mechanical input to a 
biochemical output in double emulsion as an artificial cell. I envision testing the possibility 
of mechanically regulating gene expression in artificial cells encapsulating cell free system 
as a future direction. This work also highlights the power and utility of microfluidic devices 
in synthetic biology research. Although the mechanosensitive artificial cell is quite 
primitive at this point, it is a starting point for further engineering. All life forms are 
mechanosensitive, as mechanical force influences biochemistry [161], and this work opens 




Chapter 4: Improvement of a microfluidic 
compression device for cell mechanics study 
 
4.1 Introduction 
4.1.1 Mechanobiology and microfluidics 
Cells in our body experience a myriad of mechanical stimuli over their lifetime. 
Mechanotransduction underlies cellular responses to different mechanical stimuli. The 
proper responses of the cells to any mechanical stimuli are important in maintaining the 
survival of a multicellular organism. Mechanical stimuli can be classified into either passive 
or active mechanical input [14]. Passive inputs are physical properties of the environment, 
while active inputs are mechanical forces that act directly on cells. With the development of 
microsystem engineering tools, controlled and repeatable application of passive or active 
mechanical input to single cells is becoming more available [162]. Several microfluidic 
platforms have been developed for mechanotransduction research over the last decade,[43, 
162] which includes the application of shear stress [44, 163, 164], stretching [45, 165], and 
compression[82-84] to a population of cells or a single cell. In recent years, 
mechanotransduction by compression is gaining more interest, with recognition that cells 





4.1.2 Microengineering tools for compression 
The study of mechanobiology in cell population and single-cell contexts offer 
different insights in mechanical responses from being physiologically relevant to single-cell 
heterogeneity. Different experimental techniques were developed for these studies [19]. To 
understand the heterogeneous mechanical responses of single cells to compression, 
modified atomic force microscopy (AFM) probes was developed to apply compressive 
forces to single cells [78, 79, 169, 170]. Lulevich et al. developed an atomic force 
microscopy based single-cell compression technique to measure the force and deformation 
of living cells in 2006 [78]. They also extended the technique to investigate the rigidity of 
neuronal cells under Aβ42 protein treatment [169] and the stiffness of keratinocyte cells 
[170]. Weafer et al. also used a modified AFM system to perform whole cell compression of 
osteoblasts to study the role of cytoskeleton in compression resistance of cells [79]. While 
AFM is a powerful approach to apply compressive forces and measure deformation of cells, 
this sophisticated method has a low throughput and requires an expensive equipment and 
technical expertise. Development of new microengineered tools that combine dynamic 
compression and other modes of deformation in a higher throughput manner would be 
very desirable for mechanotransduction research.  
Microfluidic devices have been extensively used in high throughput single cell 
analysis applications to precisely manipulate cells and their surrounding 
microenvironment. In the early 2000s, Quake’s lab developed multilayer soft lithography to 
build active microfluidic systems containing on-off valves and switching valves [81]. They 
further developed the system to fit thousands of micromechanical valves and hundreds of 
individually addressable chambers inside a microfluidic chip [171]. With the integration of 
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microsized and fast-operating valves in the microfluidic system, several platforms have 
been developed for studying the biological response of cells under a compressive stress 
[82-84]. Kim et al. used a microfluidic biomechanical device formed by multilayer soft 
lithography for compressive stimulation and lysis of cells [82]. Hosmane et al. developed a 
new platform that compressed locally and induced injury to micron-scale segments of 
single axons [83]. Si et al. used a similar multilayer soft lithography device and found that 
compressed E. coli grow and divide with a flat pancake-like geometry [84]. These studies 
took advantage of the high throughput nature of multilayer microfluidic devices. However, 
microfluidic platforms integrated with microvalves have not been developed for single cell 
compression.  
 
4.1.3 Improvement of the microfluidic compression device 
Previously, a microfluidic aspiration and compression device was developed to 
apply compression to single artificial cells for mechanical activation [172]. However, the 
device had several limitations in compressing cells, which spread on the surface and are 
smaller in size. The concave deflection profile of the PDMS membrane limited the ability to 
have a controlled contact area between the membrane and the cells (Figure 4-1A), 
affecting the forces applied to each cell. Moreover, cells randomly spread inside the 
microfluidic device and were rarely directly underneath the deflection membrane for 
compression (Figure 4-1B). These limitations motivated me to further improve the 
microfluidic device in order to achieve single cell compression. 
The goal of this chapter is to engineer a more versatile microfluidic platform for 
mechanobiology research. I modified the design of the previous microfluidic device to 
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apply more a uniform compressive force to single cells. I will first describe the modification 
of design, followed by the characterization of the device. Finally, I will describe cellular 
relaxation to static and cyclic compression. Overall, the newly designed microfluidic device 
provides a platform for applying static or cyclic compression on single cells.  
 
4.2 Microfluidic device overview and design 
To eliminate the concave deflection profile of the membrane, I spatially varied the 
thickness of the membrane to create a difference in bending rigidity across the membrane, 
since bending rigidity depends on the elastic modulus of the membrane and the membrane 
thickness. While it is not easy to fabricate a device with different elastic modulus in the 
membrane, I decided to include a block of PDMS to change the thickness of the membrane 
in the middle of the membrane (Figure 4-2). In this case, the membrane in the middle will 
have a higher resistance to deform comparing to the membrane on the side. This, then, 
Figure 4-1: Limitations in previous microfluidic compression device for 
compression of cells 
(A) Image from confocal microscopy of fluorescent dye perfused in the microfluidic 
channel. Z-stack images were reconstructed in ImageJ to generate side view images. 
(B) Brightfield image showed the random spreading of cells inside the microfluidic 
device, as pointed out by the arrowhead. 
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could create a flat deflection profile in the middle of the membrane, while having a concave 
deflection profile on the side.  
To avoid random spreading of cells inside the microfluidic device, I modified the 
device fabrication procedures so that multiple fibronectin islands could be printed 
underneath the deflection membrane, where cells will only be able to spread on the 
fibronectin islands. 
The modified microfluidic device, made out of polydimethylsiloxane (PDMS), has 
two layers, the flow layer (blue) and the control layer (orange) (Figure 4-3A), similar to 
the previously designed microfluidic device [172]. The flow layer has a similar design, 
where fluid and cells flow from two inlets through the microfluidic channel to one outlet. 
An extra inlet was added to allow quicker and easier fluid exchange for different biological 
assays. The microfluidic channel first splits into two channels, each containing 18 
compression chambers. Each compression chamber is connected to the opposing end of the 
Figure 4-2: Modification of the thickness in the middle of the membrane 
The thickness of the membrane was designed to be larger in the middle comparing 
to the side. This creates a difference in bending rigidity throughout the membrane. 
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main microfluidic channel through a small microchannel. The microfluidic channel was 
designed so that the flow resistance of the main microfluidic channel is 20 times smaller 
than that of the small microchannel. This allows the majority of fluid to flow into the main 
microfluidic channel. A thin PDMS membrane separates the microfluidic channel and the 
control layers that serves two different functions and are independently controlled. Two 
pneumatically controlled valve sets located above the main microfluidic channel and above 
the compression chambers were used to direct flow to the compression chambers and to 
compress cells respectively.  
To apply a uniform compressive force on cells, fibronectin was microncontact-
printed underneath the block that was designed to be at the center of the compression 
chamber (Figure 4-3A, B). When cells were loaded into the device, the cells would be 
trapped inside the compression chambers, due to the pressure difference across the 
Figure 4-3: Schematic showing the design of the microfluidic device 
(A) Top view of the flow layer and control layer design at the compression chamber. 
Rectangular block was added to the design for achieving a more uniform deflection. 
(B) Side view of the microfluidic device when the control layer was uncompressed 
(top) and compressed (bottom). Fibronectin patterns were microcontact-printed 
underneath the block inside the compression chamber to control the positions 
where cells spread. 
 
 77 
microchannel. After a cell spreads on the fibronectin pattern, it can then be compressed by 
increasing the pressure in the control layer that deflects the membrane (Figure 4-3B). 
 
4.3 Materials and methods 
4.3.1 Membrane deflection simulation 
Membrane deflection in the compression chamber of the microfluidic device was 
simulated using COMSOL 4.4 (COMSOL Multiphysics). The membrane and the block in the 
compression chamber can be simplified and characterized by block width, compression 
chamber width, block thickness and membrane thickness. To determine the optimal design 
of the device, a simplified three-dimensional model of the membrane and block was 
constructed in COMSOL and was simulated using the solid mechanics module. The PDMS 
was modeled as a linear elastic material with elastic modulus of 0.3 MPa, a Poisson’s ratio 
of 0.49 and a density of 970 kg/m3. A uniform pressure of 10 psi was applied as boundary 
load on top of the membrane, while the four sides of the membrane were set as fixed. 
For the demonstration that the membrane and the block will deflect as predicted, a 
three-dimensional model of the device was also constructed in Solidworks with the block 
width as 40 µm, the compression chamber width as 80 µm, the block thickness as 20 µm 
and the membrane thickness as 30 µm. The deflection of the membrane and the block was 
simulated using COMSOL 4.4 as well with the same simulation module, material properties 





4.3.2 Device fabrication 
The microfluidic device was fabricated using multilayer soft lithography technique 
[149]. The microfluidic device is composed of a PDMS control layer, a PDMS flow layer and 
a fibronectin printed glass coverslip, of which were aligned and bonded permanently 
together. Schematic of the fabrication process flow of the microfluidic device is illustrated 
in Figure 4-4. 
Three photomasks were produced by high resolution inkjet printing on 
transparency film (CAD/Art Services) for SU-8 patterning of four silicon molds by standard 
photolithography. The first silicon mold is composed of one layer of SU-8 pattern for PDMS 
casting of the control layer. The SU-8 pattern of the control layer defined two sets of 
integrated microfluidic control valves for closing of the main microfluidic channel (Control 
valve set 1) and deflection of the flow layer in the trapping chambers for planer 
compression of cells (Control valve set 2) respectively. These two sets of microfluidic 
control valves contained two independent inlets. The second silicon mold is composed of 
three layers of SU-8 patterns to be used for PDMS spin-coating of the flow layer. The first 
SU-8 patterning layer defined the side microfluidic pipette channel for trapping the cells. 
The second SU-8 patterning layer defined the compression block for flat planar 
compression of cells. The third SU-8 patterning layer defined the main microfluidic 
channel, the trapping chambers, the inlets and the outlet. The third silicon mold is 
composed of one layer of SU-8 pattern for PDMS casting of the bottom alignment layer. The 
SU-8 pattern of the bottom alignment layer has the same design as the third SU-8 
patterning layer of the second silicon mold, so that the bottom alignment layer can be used 
for aligning the fibronectin and the PDMS control/flow substrate. The fourth silicon mold is 
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Figure 4-4: Fabrication process of microfluidic device 
Four silicon molds for control layer, flow channel, bottom alignment layer and 
microcontact printing layer were casted with PDMS, demolded, cut, aligned, bonded, 
surface treated at different stages as shown in the figure. 
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composed of one layer of SU-8 pattern for PDMS casting of the microcontact printing layer. 
The microcontact printing layer has different shape and size for printing fibronectin right 
underneath the compression chambers.  
The SU-8 patterning procedures of the four silicon molds followed the standard 
protocol developed by Microchem, Inc. for SU-8 2000 [150]. First, four silicon wafers were 
dehydrated on a hotplate at 200oC for 15 min to promote photoresist adhesion. In SU-8 
patterning the silicon mold for the control layer, SU-8 2025 was spin-coated at 4000 rpm 
onto the wafer for 30 s, which gave a thickness of 20 µm. The photoresist was then exposed 
to UV light for 12 s under a contact aligner (Karl Suss, MJB45). In the first SU-8 patterning 
of the flow layer, SU-8 2005 was spin-coated at 2700 rpm onto the silicon wafer for 30 s, 
which gave a thickness of 5.4 µm. The photoresist was then exposed to UV light for 9 s with 
the first flow channel photomask, which defined the side pipette arrays. After development 
of first SU-8 layer, the silicon wafer was hard-baked at 200oC for 20-30 minutes to 
consolidate the developed SU-8 patterns before the application of the second SU-8 layer. 
Subsequently, for the second layer SU-8 patterning of the flow layer, SU-8 2025 was spin-
coated at 3500 rpm onto the silicon wafer for 30 s, which gave a combined thickness of 24 
µm. The photoresist was then aligned with the second flow channel photomask, which 
mainly defined the compression block, and exposed to UV light for 11.5 s. After 
development of SU-8, both silicon molds were hard-baked at 200oC for 20-30 minutes to 
consolidate the developed SU-8 patterns before the application of the third SU-8 layer. 
Subsequently, for the third layer SU-8 patterning of the flow layer, SU-8 2025 was spin-
coated at 2100 rpm onto the silicon wafer for 30 s, which gave a combined thickness of 38 
µm. The photoresist was then aligned with the third flow channel photomask, which mainly 
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defined the main microfluidic channel, and exposed to UV light for 12.5 s. In SU-8 
patterning the silicon mold for the bottom alignment layer, SU-8 2010 was spin-coated at 
2000 rpm onto the wafer for 30 s, which gave a thickness of 13 µm. The photoresist was 
then exposed to UV light for 9 s under a contact aligner. In SU-8 patterning the silicon mold 
for the microcontact printing layer, SU-8 2025 was spin-coated at 4000 rpm onto the wafer 
for 30 s, which gave a thickness of 20 µm. The photoresist was then exposed to UV light for 
12 s under a contact aligner. After development of SU-8, all four silicon molds were hard-
baked at 200oC for 20-30 minutes again to cure any surface cracks. The thicknesses of both 
the control layer and flow channel SU-8 pattern were measured using a stylus profilometer 
(Dektak 6M). 
Before PDMS casting or spin-coating on the silicon molds, all four wafers were first 
silanized with trichloro(1H,1H,2H,2H-perfluorooctyl)silane (Sigma-Aldrich) in a desiccator 
for 1 hour. The silicon mold for the control layer was casted with PDMS (Sylgard-184) with 
a mixing ratio of 7:1 (base:curing agent), while both the silicon mold for the bottom 
alignment layer and the microcontact printing layer were casted with PDMS with a mixing 
ratio of 10:1. After degassing in a desiccator, the control layer, bottom alignment layer and 
microcontact printing layer PDMS substrate were then cured at 60oC overnight before 
demolding from the wafer. The control layer PDMS substrate was then diced and holes 
were punched with 1 mm diameter at the inlets of the microfluidic control valves, while the 
bottom alignment layer and microcontact printing layer PDMS substrates were also diced. 
The flow channel membrane was generated by spin-coating PDMS with a mixing ratio of 
20:1 (base:curing agent) on the flow layer silicon mold at rotational speeds 1200 rpm for 
60 s. After this, the PDMS flow layer membrane was cured at 60oC for 2 hours. Both the 
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diced PDMS control substrate and the PDMS flow layer membrane on the silicon mold were 
placed in an oxygen plasma etcher (Femto, Covance) to render the PDMS surfaces 
hydrophilic for the preparation of bonding procedure described as follows. The flow layer 
silicon mold containing the PDMS membrane was mounted on a customized alignment 
platform on an optical microscope. The diced PDMS control layer substrate was then 
carefully aligned and bonded with the PDMS flow layer membrane. The permanent bonding 
between the control layer substrate and PDMS flow layer membrane was established by 
heating in the oven at 60oC overnight with the aid of gentle pressing between two 
substrates.  
The day after, the bonded control layer substrate with the flow layer membrane was 
then cut out and peeled off from the flow layer silicon wafer. Inlet and outlet holes (1 mm 
diameter) for the main microfluidic flow channel were punched through the layer PDMS 
control/flow substrate. The bottom alignment substrate which had the similar channel of 
flow layer was used to align the fibronectin with flow layer. First, PDMS microcontact 
printed substrate was aligned with the bottom alignment substrate to print the fibronectin 
on a PDMS-coated glass coverslip. Then the PDMS microcontact printed substrate was 
removed. Immediately, the PDMS control/flow substrate was placed in an oxygen plasma 
etcher to render PDMS surface hydrophilic before aligning with the bottom alignment 
substrate and permanently bonding to the fibronectin-printed glass coverslip. The device 





4.3.3 Microcontact printing 
We incubated 40 µg/ml fibronectin on the PDMS stamp for 1 hour to coat 
fibronectin on its surface. A PDMS-coated coverslip was oxidized by UV-ozone. The bottom 
alignment substrate would be placed under a PDMS-coated coverslip and aligned with a 
fibronectin-coated PDMS stamp. The fibronectin is printed onto the PDMS-coated coverslip 
when the pattern comes into conformal contact with it. We used a mixture of fibrinogen 
conjugated with Alexa Fluor 647 (ThermoFisher Scientific, F35200) and fibronectin and 
checked the positions of fibronectin island using a spinning disk confocal microscope 
(Olympus IX73 with Yokogawa CSU-X1). The device was washed with 0.1% Pluronic F127 
solution for 1 hour to passivate the remaining surface and then washed with PBS for 1 
hour.  
 
4.3.4 Visualization of flow streamlines.  
1 m Y (yellow)-G (green) fluorescent beads (Invitrogen; 1:1000 dilution in DI 
water) were introduced into the device at a flow rate of 1 µl/min and were imaged with a 
high exposure time to observe the flow streamlines. The PDMS microfluidic device was 
perfused with DI water first to eliminate any trapped air bubbles before use. Fluorescence 
images were captured using an epi-fluorescence microscope (Nikon, Ti Eclipse) with 500 
ms exposure time to generate streamlines to show the trajectory of the traveling fluid.  
 
4.3.5 Imaging membrane deflection and 3D image reconstruction.  
Rhodamine succinimidyl dye was perfused into the device and we made sure there 
was no air bubble inside. A spinning disk confocal microscope (Olympus IX73 with 
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Yokogawa CSU-X1) was used for imaging the dye solution at 20X. The control layer inlets 
(Control valve set 2) of the microfluidic device was connected to a pressure regulator 
(Norgren R07-200-RGEA). The membranes above the chambers were deflected by 
changing the air pressure in the Control valve set 2 between 0 psi-30 psi. A z-series of 
fluorescence images, excited at 561 nm, was captured at a step size of 500 nm and was 
reconstructed in ImageJ to generate 3D and side view images. 
 
4.3.6 Preparation of cell lines.  
Non-tumorigenic epithelial cell MCF-10A cells were cultured in growth media 
DMEM premixed 1:1 with Ham’s F12 nutrient mixture with 5% horse serum, 1% pen-strep, 
2.5 g/ml amphotericin B (fungizone), 5 g/ml gentamycin, 10 µg/ml insulin, 0.5 g/ml 
hydrocortisone, 0.02 g/ml epidermal growth factor, and 0.1 g/ml cholera toxin at 5% 
CO2 and 37oC until about 70% confluency. 5 g/ml Hoechst dye in PBS was used to label 
the nucleus. Stable cell lines expressing eGFP and Lifeact-RFP were generated via lentiviral 
transduction for labeling the cell volume and actin respectively. Cells were suspended at 
106 cells/ml to minimize cell clumping and possible pressure fluctuation during the 
experiment.  
 
4.3.7 Cell trapping, seeding and compression.  
The PDMS microfluidic device was perfused with warm medium before MCF-10A 
cells with a concentration of 106 cells/ml were introduced into device for trapping single 
cells. To trap cells in the trapping chambers, Control valve set 1 was then pressurized at 20-
30 psi to block the main microfluidic channel, which increased the flow resistance in the 
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main microfluidic channel. After the cells were trapped, the device was placed in an 
incubator for 4 hours to allow cell attachment and spreading on the fibronectin-patterned 
surface. An electro-regulator (Proportion-Air, QBX) was set up, which was connected to a 
pressure regulator, and a computer program was used to control the pressure. Pressure 
from 0 psi to 15 psi was applied to the control layer that deflected the membrane for cell 
compression. Each pressure was maintained for 3 minutes and z-series of fluorescence 
images were acquired at excitations of 488 nm, 561 nm, and 405 nm with 500 ms exposure 
time, at a step size of 500 nm. For cyclic compression, the cells were compressed at 0.5 Hz 
for 6 minutes. 
 
4.4 Results and discussion 
4.4.1 Cell size and height 
In order to design a device that is best suited for compressing MCF-10A cells, we 
first measured MCF-10A cell size and height in suspension and attached on a surface. Z-
stack fluorescence confocal images were taken using a spinning disk confocal microscope 
(Olympus IX73 with Yokogawa CSU-X1) and were reconstructed in ImageJ to generate side 
view images (Figure 4-5A, B). MCF-10A cells in suspension have an average height of 18.8 
µm, while attached MCF-10A cells have an average height of 14.1 µm (Figure 4-5C). By 
looking at the top view of the attached MCF-10A cells, they spread across a distance of 20-
40 µm (data not shown). The size and height of free or attached MCF-10A cells provide a 




4.4.2 Geometric parameters of the device for cell compression 
Four different geometric parameters of the compression chamber need to be 
determined for designing the device to apply uniform compression on MCF-10A cells. The 
membrane and the block in the compression chamber can be simplified and characterized 
by block width, compression chamber width (w), block thickness (hb) and membrane 
thickness (hm) (Figure 4-6A). Since the MCF-10A cells have a spreading area of 20-40 µm, 
the block width was set as 40 µm to ensure that the cells are spread underneath the block 
even there is some misalignment during device fabrication. The separation between the 
block and the bottom cell attachment surface was set to be around 20-25 µm because of the 
MCF-10A cells when they are in suspension. While the height of the MCF-10A cells is 
Figure 4-5: MCF-10A cell side view and height in suspension and attached on a 
surface 
(A) Side view fluorescence image of MCF-10A cell attached on a surface. (B) Side 
view fluorescence image of MCF-10A cell in suspension. (C) The average height of 
MCF-10A cells when floating or spread on a surface. 
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around 14 µm when they spread, I chose the optimal membrane deflection to be around 
10-15 µm when a pressure of 10 psi is applied. 
To determine the other three parameters for optimal compression, I performed 
solid mechanics simulation of a simplified membrane and block model using COMSOL. The 
displacement of the block was determined for the 27 conditions where we permutated the 
values of the three variables (Figure 4-6B). Based on the simulation results, the 
compression chamber width and membrane thickness were set as 80 µm and 30 µm 
Figure 4-6: Simulation results for determining the geometric parameters of the 
device for cell compression 
(A) Simplified membrane and block model for simulation. Three geometric 
parameters were defined as compression chamber width (w), block thickness (hb) 
and membrane thickness (hm). (B) Displacement of the simplified membrane and 
block model at different values of geometric parameters. (C) Vertical displacement 
of the membrane and block at different horizontal position across the compression 
chamber with different block thickness. (D) Displacement of the simulated result for 
the complete device model. 
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respectively. For the block thickness, we plot the displacement of the membrane and block 
with respect to the horizontal position across the compression chamber (Figure 4-6C). By 
changing the block thickness from 0 µm to 30 µm, we can readily see that the original 
concave deflection profile (black line, 0 µm) was minimized when the block thickness was 
increased to 20 µm (blue line) or higher. Therefore, the block thickness was set at 20 µm.  
After the three parameters were set, I performed solid mechanics simulation of the 
complete device model with the parameters that were chosen using COMSOL. At a pressure 
of 10 psi, the membrane and block deflect around 10-15 psi as expected (Figure 4-6D), 
confirming that the results of the simplified membrane and block model were 
representative. 
 
4.4.3 Flow streamlines and membrane deflections by pneumatic control 
The microfluidic device has two sets of control valve for enhancing trapping and for 
the compression of cells respectively, similar to a previous design described in Chapter 3 
[172]. Control valve set 1 features rectangular patterns across the main microfluidic 
channels. When Control valve set 1 is pressurized, the PDMS membrane above the main 
microfluidic channels deflects and the flow resistance in the main microfluidic channels is 
increased. This leads to a change in the flow profile to direct the flow to the compression 
chambers, thereby trapping cells. Control valve set 2 features rectangular patterns directly 
above each compression chamber. When Control valve set 2 is pressurized, the PDMS 
membrane above the compression chambers deflects and compresses the attached cells in 
the compression chambers.  
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From the simulation results in section 4.4.2, we obtained the following geometric 
parameters for the microfluidic device: block width of 40 µm, compression chamber width 
of 80 µm, block thickness of 20 µm, and membrane thickness of 30 µm. Therefore, we 
fabricated the microfluidic device according to the method described in section 4.3.2. To 
verify whether the simulation result is indeed the optimal design, we varied the 
compression chamber width and characterized the trapping efficiency and membrane 
deflection for compression.  
To examine the trapping efficiency of the device when the Control valve set 1 was 
pressurized, we imaged the flow streamline inside the main microfluidic channel and the 
compression chamber. By flowing small fluorescent beads inside the microfluidic device, 
the beads will trace the streamlines of the fluid. When the beads are imaged at a high 
exposure time, the flow streamlines are captured. With increasing pressure applied the 
Control valve set 1, more fluid streamline entered the compression chamber (Figure 4-7A). 
This indicates an increase in trapping efficiency. Among the three different compression 
chamber widths of 60, 80, 100 µm, the device with 80 µm has the best trapping efficiency 
when the pressure in the Control valve set 1 was increased, and thus was used for the 
subsequent studies. 
To examine the deflections of membrane with different compression chamber width 
as a function of different applied pressures, I labeled the microfluidic channel volume with 
rhodamine succinimidyl dye since the PDMS membrane cannot directly label easily. When 
Control valve set 2 was pressurized, the membrane deflected and displaced the fluid in the 
microfluidic channel so that I could indirectly visualize membrane deflection. The 3D and 
side view images of the compressed compression chamber were reconstructed and showed 
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the increase in membrane deflection with increasing compression chamber widths (Figure 
4-7B, left). Importantly, when the membrane deflected, the bottom of the block remained 
Figure 4-7: Flow streamlines and membrane deflection characterization in device 
with different compression chamber widths 
(A) Brightfield images of the compression chamber and fluorescence images of the 
fluorescent beads of different widths were shown when the Control valve set 1 was 
pressurized (Scale bar = 60 µm). (B) (left) Membrane deflection of different 
compression chamber widths were characterized in different pressure applied. 
(Right) Reconstructed 3D and side view images of 80 µm chamber width at different 
Control valve set 2 pressures. Scale bar = 40 µm. 
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flat while the side membrane is concave (Figure 4-7B, right), demonstrating the block 
design was effective at providing a uniform compression. 
 
4.4.4 Alignment of microcontact-printed fibronectin for the attachment and compression of 
cells 
Microcontact printing of fibronectin inside the device controls the position and 
extent of cell spreading. The alignment of the microcontact printed fibronectin with the 
compression chamber is very important, as it will control the position of cell spreading 
underneath the block for uniform compression. Our customized alignment platform on an 
optical microscope does not support fluorescence imaging. Therefore, the microcontact 
printing of fibronectin was aligned with the compfression chamber of the device through a 
two-step alignment with a reference bottom alignment layer. The fabrication methods 
were described in section 4.3.2. After the alignment and the fabrication of the device, the 
fluorescent fibronectin was imaged and was verified to locate underneath the block inside 
the compression chamber, as desired (Figure 4-8A).  
After the alignment of the microcontact printed fibronectin to the compression 
chamber, I verified if the fabrication steps and cell trapping methods did not affect the 
spreading of cell on the fibronectin island. The brightfield image of the compression 
chamber, fluorescence image of the fibronectin, fluorescence image of the nucleus and actin 
of the MCF-10A cell were imaged using a confocal microscope (Figure 4-8B). This 
demonstrated that the device still provides a desired environment for the spreading of the 
cells.  
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When the cells are spread on the fibronectin island, the cell can be compressed by 
the deflection of the PDMS membrane. As the pressure of the Control valve set 2 increases, 
the cell was compressed at 10 psi slightly and further compressed at 15 psi, as shown in the 
reconstructed side view images of the MCF-10A cell at different pressure applied (Figure 
4-8C). This demonstrated the ability of the device to control different extent of 
compression on cells. 
Apart from static compression, the new microfluidic device can apply cyclic 
compression to the cell by alternating the pressure between high and low values. The cell 
will experience repetitive compression and relaxation cycle. The pressure of the Control 
Figure 4-8: Alignment of microcontact-printed fibronectin for the attachment and 
compression of cells 
(A) Brightfield and fluorescence images of the device and fibronectin respectively. 
Scale bar = 50 µm. (B) Zoom-in brightfield and fluorescence image of the device and 
fibronectin respectively (left). Fluorescence image of the MCF-10A cell, labeling the 
DNA (blue) and actin (red) (right). Scale bar = 20 µm. (C) Reconstructed side view 
image of the MCF-10A cell when the pressure of the Control valve set 2 was 
increased from 0 to 15 psi. Blue: DNA; Red: actin. Scale bar = 10 µm.  
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valve set 2 was set to alternate between 10 and 15 psi at 0.5 Hz. After 6 minutes of cyclic 
compression, the cell was imaged and the reconstructed side view images show a slight 
reduction in height immediately after the compression and surprisingly a slight increase in 
height at 11 minutes after the cyclic compression compared to before cyclic compression 
(Figure 4-9), suggesting that the MCF-10A cell might respond to the cyclic compression 
and grow taller. 
 
4.5 Conclusions 
In this work, I have developed a new microfluidic device, which introduces a 20 µm 
thick PDMS block underneath the PDMS membrane to the microfluidic device described in 
Chapter 3 in order to apply uniform compression on cell. I also incorporated microcontact 
printed fibronectin islands that were aligned to be underneath the block in order to control 
the location of cell spreading. The design allowed the application of uniform compression 
on isolated single cells in a higher throughput manner. The device consists of a flow 
channel for trapping and spreading of cells and a control layer for trapping and 
compression. Another two PDMS substrates were used to print fibronectin on a PDMS-
coated glass coverslip and facilitates the alignment of the device with the fibronectin 
patterns. By connecting a syringe pump to the flow channel and a computer controlled 
Figure 4-9: Images of cell before and after cyclic compression 
Fluorescence side view images of the MCF-10A cell, labeling the DNA (blue) and 
actin (red), when the pressure of the Control valve set 2 was alternating between 10 
and 15 psi at 0.5 Hz for 6 minutes. Scale bar = 10 µm. 
 
 94 
electro-regulator to the control layer, the device is able to apply static or cyclic 
compression on isolated, micropatterned single cells. 
The development of the microfluidic device and the application of static or cyclic 
compressive loading to single cells have provided us the opportunity to study the 
mechanics of cells and cellular mechanotransduction pathways. Although the fabrication of 
the microfluidic device is still complicated, it has a potential to provide a higher throughput 
and an easier setup for compression of single cells. Collectively, the microfluidic device 








5.1.1 Cancer invasion and metastasis 
The activation of invasion and metastasis is one of the hallmarks in cancer [173]. It 
is characterized as the migration from the original tissue to invade adjacent tissues or 
distant organs. The behavior is mainly due to the aberrant regulation of cell migration in 
cancer cells, which is mainly driven by the protrusion of actin cytoskeleton [174]. One of 
the protrusive structures formed by cancer cells is invadopodia. Invadopodia is a dynamic 
ventral actin protrusion at the attachment and degradation sites on the extracellular matrix 
[175]. Different actin regulators, such as cortactin and N-WASP, and adaptor proteins, like 
Tks4 and Tks5, are the key proteins present in invadopodia. Invadopodia formation is 
regulated by Src signaling, which is negatively regulated by focal adhesion kinase (FAK) 
[176]. Invadopodia have been shown to degrade the extracellular matrix using a gelatin 
degradation assay [177]. Invadopodia are usually present in invasive cancer cells and play 
an important role in cancer invasion and metastasis. Thus, these dynamic and specialized 





5.1.2 Compression in tumor microenvironment 
Uncontrolled cell proliferation is another hallmark in cancer [173]. Due to the 
uncontrolled division of cancer cells, solid pressure builds up in tumors and contributes to 
the increase in compressive forces on cancer cells [60] as well as to the cells in the 
surrounding normal tissue.  
The effect of compressive forces on cancer cell behavior has been investigated 
before. Earlier work embedded cancer cells in agarose gels and established that 
microenvironmental mechanical stress inhibits tumor spheroid growth [178] and induces 
apoptosis via the mitochondrial pathway [166]. In another tumor spheroid study, it was 
found that the suppression of cell proliferation depends on the pressure-induced volume 
change and cell cycle regulation [179]. A recent study using a 2D cell monolayer strategy 
investigated the effect of compression on cancer cell invasion [168]. It was found that 
compression increases leader cell formation around the entire free-cell perimeter 
comparing to only in the corners of the square islands of a cell population. This work 
showed that mechanical compression can remodel the actin cytoskeleton and enhances 
cancer cell motility. The above in vitro studies concluded that despite the inhibition of 
proliferation and the induction of apoptosis, compression drives cancer cells toward an 
invasive phenotype. It is also supported by a recent study in an animal model where 
tumorigenic β-catenin pathway was induced at an applied 1200 Pa stress on normal and 
healthy colon tissue [180], supporting the idea that compressive stress potentially drives 




5.1.3 Mechanosensing and mechanotransduction through actin cytoskeleton 
Actin cytoskeleton plays an important role in mechanotransduction. Apart from 
providing mechanical strength for cells to withstand external forces such as compression 
and dynamically remodeling to provide different structures for cell motility, the actin 
cytoskeleton also plays a role in mechanosensing. A key feature of actin cytoskeleton 
network is that it is in a prestress state, as governed by the tensegrity model [181, 182]. 
This property of the actin cytoskeleton ensures quick, sensitive and coordinated 
mechanotransduction responses. The actin cytoskeleton is organized by actin-binding 
proteins and prestressed by the myosin motor proteins. The actin-binding proteins also 
serve as mechanosensors under forces. When actin filaments and actin network are under 
compressive forces, the force alters the conformation of the prestressed actin network and 
thus its affinity to the actin-binding proteins [183]. The actin network also transmits forces 
to other structures in the cell. These contribute to the transduction of mechanical signals 
into biochemical signals.  
Actin cytoskeleton is very important in the mechanobiology of cells under 
compression. It is a sensitive mechanosensor that can sense the compressive force. Since it 
was shown that compression drives invasive phenotype, we hypothesized that 
compression also drives the formation of other protrusive structures in cells, such as 
invadopodia.  
 
5.1.4 Compression on monolayer cell 
Due to the tensegrity property of tissues, different cells experience different 
combinations of compressive, tensile and shear stresses when compression is applied to 
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the tissue. To determine how compression is sensed and transduced inside the cells, we 
chose to apply compression to monolayer of cells in an uni-directional manner so that the 
effect of compression can be specifically studied. 
The goal of this chapter is to further investigate the effect of compression on cells 
focusing on the remodeling of actin cytoskeleton. I applied compression to a monolayer of 
non-tumorigenic epithelial cells and mammary carcinoma cells and for the first time 
observed actin protrusions at the apical surface of the cells, in the direction of the 
compressive load. I further investigated whether these actin protrusions were invadopodia 
or not via immunofluorescence staining of actin regulator cortactin and adaptor protein 
Tks5, Western blot and drug inhibition of Src signaling and gelatin degradation assay. 
Overall, this study showed the formation of apical actin protrusions under high 
compression that are structurally but may not be functionally similar to invadopodia in 
normal cells.  
 
5.2 Materials and methods 
5.2.1 Preparation of cell lines 
Two cell lines were used in this study, non-tumorigenic epithelial cell MCF-10A and 
mammary carcinoma cell MDA-MB-231. MCF-10A cells were cultured in growth media 
DMEM premixed 1:1 with Ham’s F12 nutrient mixture with 5% horse serum, 1% pen-strep, 
2.5 g/ml amphotericin B(fungizone), 5 g/ml gentamycin, 10 µg/ml insulin, 0.5 g/ml 
hydrocortisone, 0.02 g/ml epidermal growth factor, and 0.1 g/ml cholera toxin. MDA-
MB-231 cells were cultured in growth media RPMI1640 with 10% FBS, 1% pen-strep, 2.5 
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g/ml amphotericin B (fungizone), and 5 g/ml gentamycin. All cells were incubated at 
37oC with 5% CO2. 
5 g/ml Hoechst dye in media was used to label the nucleus. Stable cell lines 
expressing eGFP and Lifeact-RFP were generated via lentiviral transduction for labeling the 
cell volume and actin filaments respectively. 
 
5.2.2 Preparation of agarose gel 
1%, 2%, 4% and 8% agarose gels were made by dissolving different amounts of 
agarose powder (Invitrogen, UltraPure Agarose, 16500-100) in hot 1X PBS solution. The 
agarose gels were then autoclaved to sterilize the agarose solution. A sterilized PDMS mold 
with 24 mm holes was used for forming agarose gels with 24 mm diameter. 1 ml of hot 
agarose solution was added to the mold and allowed to cool down at room temperature. 
Once the agarose cooled down and hardened, the agarose gels were removed and 
immersed in corresponding culture media before use.  
 
5.2.3 Compression of cells 
The cells were compressed on a 27-mm glass bottom dish (Thermo Scientific, Nunc). 
First, 150,000 cells were seeded onto each glass bottom dish the day before compressing 
the cells. Then, a sterilized plastic cap with specified weight was used to apply a constant 
force to the agarose gel, which was placed on top of the cells. The entire compression setup 
was placed in the incubator for 30 minutes of compression. For control samples, the 
agarose gel was applied without the plastic cap. For most of the experiments, the weight 
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was 27.7 g or 55.3 g, while the area of the agarose gel was 452 mm2, which translates to a 
compressive stress of 600 Pa or 1200 Pa respectively.  
 
5.2.4 Live-cell imaging 
The glass bottom dish was mounted in a temperature-controlled stage on a spinning 
disk confocal microscope (Olympus IX73 with Yokogawa CSU-X1). The temperature was 
controlled so that the media was kept at 37oC. The nucleus, cell volume and the actin 
structures were imaged before and 30 minutes after 600 Pa or 1200 Pa of compression. Z-
stack images with 200 nm step size were captured and the side view images were 
reconstructed by using ImageJ.  
 
5.2.5 Immunofluorescence  
The cells were first compressed with 1200 Pa for 30 minutes. Before the removal of 
the weight, all the media was aspirated and 4% PFA in PBS was added for fixation. After 5 
minutes of incubation, the weight was removed. The agarose gel was immediately 
incubated with fresh 4% PFA for another 5 minutes. The bottom surface of the agarose gel 
was washed, permeabilized, incubated with 3% BSA for 45 minutes, stained with primary 
antibodies and secondary antibodies, similar to a typical immunofluorescence labeling 
procedure. Primary antibodies used included anti-cortactin (Abcam, ab81208) and anti-





5.2.6 Gelatin assay 
This protocol is adapted from Rachel et al 2015 [184]. The agarose gel was first 
coated with gelatin by placing 100 μl of gelatin solution on the 1% agarose gel for 10 
minutes. The gelatin solution was a mixture of 0.1% fluorescein isothiocyante (FITC)-
gelatin (Invitrogen) and 2% porcine gelatin in PBS in a volume ratio of 1:9. The agarose gel 
was then treated with 0.5% gluteraldehyde/PBS for 10 min, washed in PBS and incubated 
for 3 min in 5 mg/ml sodium borohydride (NaBH4). Finally, the agarose gel was rinsed in 
PBS and incubated at 37° in 10% fetal bovine serum/DMEM/F12 for 30min before use. The 
cells were then compressed and imaged according to the immunofluorescence method 
above. 
 
5.2.7 Preparation of cell lysate and Western blot 
The cells were first compressed with 1200 Pa for 30 minutes. Before the removal of 
the weight, all the media was aspirated and CHAPS lysis buffer was added. CHAPS buffer 
has a composition of 40 mM HEPES at pH 7.5, 120 mM NaCl, 1 mM EDTA, 10 mM 
pyrophosphate, 10 mM glycerophospate, 50 mM NaF, 1.5 mM Na3VO4 and 0.3% CHAPS. 
After the removal of weight and incubation in CHAPS lysis buffer for 10 minutes on ice, the 
samples were then centrifuged at 16,100 g for 15 minutes at 4oC to separate the 
supernatant and the pellet. The supernatant was mixed with 4x SDS sample buffer and was 
denatured for 5 minutes at 95oC. Samples were run on SDS-PAGE and stained with 
SimplyBlue SafeStain (Thermo Fisher Scientific). Samples were transferred to a 
nitrocellulose membrane. The membrane was washed, blocked by 5% milk, and probed 
using anti-Src (Cell signaling, 2108S) and anti-p-Src (Cell signaling, 2101S) antibodies. 
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Three independent experiments were performed to confirm the obtained result. Intensity 
of gel bands was quantified using Image Studio Lite software. 
 
5.3 Results and discussion 
5.3.1 Apical actin protrusion in cells under normal compression 
Under mechanical loading, the actin cytoskeleton deforms and remodels due to the 
binding and unbinding of different crosslinkers. Various signaling pathways may also 
become activated by the mechanical input, leading to the reinforcement of the actin 
cytoskeleton [71-73]. To study the remodeling of actin cytoskeleton under mechanical 
compression, I applied normal compression to a layer of cells seeded on a glass substrate 
with agarose gel and weight on top.  
Surprisingly, after 30 minutes of compression at 1200 Pa, actin protrusions were 
observed at the apical surface of the MCF-10A cells (Figure 2-1Figure 5-1). The direction of 
actin protrusions is vertical, along the same direction of the compressive force and into the 
1% agarose gel. This behavior is pressure dependent, as a lower compression pressure of 
800 Pa did not result in the emergence of actin protrusions. The emergence of actin 
Figure 5-1: Emergence of actin protrusions on the apical surface of MCF-10A cells 
Side view fluorescence images of MCF-10A cell under 0, 800, 1200 Pa compressive 
stress; DNA (blue), cytosol (green) and actin (red). Scale bar = 10 µm. 
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protrusions can also be found at the apical surface of mammary carcinoma cell, MDA-MB-
231 (Figure 5-2). This is the first time that vertical actin protrusions were observed at the 
apical surface of cells under high normal compression. 
 
5.3.2 Emergence of actin protrusions depends on agarose gel pore size 
It was observed that the actin structures stayed inside the agarose gel when the 
weight and agarose gel were removed, suggesting that the actin protrusions entered into 
the agarose gel. To test whether the agarose gel pore size might influence the formation of 
actin protrusions at the cell-gel interface, we varied the concentration of the agarose in the 
gel effectively changing the pore size of the agarose gel. It was reported that the pore size of 
agarose gel reduces with concentration of agarose from 100-200 nm at 1% agarose to 50 
nm at 3% agarose [185]. With the agarose concentration between 1% and 4%, actin 
protrusions were still observed at the apical surface of the MCF-10A cells (Figure 5-3). 
However, when the pore size of agarose further reduces (8% agarose), then actin 
protrusions were not observed.  
 
 
Figure 5-2: Actin protrusions appeared in apical surface of MDA-MB-231 cell 
Side view fluorescence images of actin structure in MDA-MB-231 cell under 0 and 
1200 Pa. Scale bar = 10 µm. 
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5.3.3 Molecular structure and functions 
We suspected that the actin protrusions found at the apical surface of the cells have 
a similar structure as invadopodia [186] or mechanopodia [74]. Cortactin, an actin 
nucleation promoting factor, and Tks5, an invadopodia scaffold protein, are two common 
markers for invadopodia and are often found in invadopodia. To further examine the 
structure of the actin protrusions, we immunostained the agarose gel after the gel was 
peeled off and tested the presence of cortactin and Tks5 proteins at the actin structures 
trapped in the agarose gel.  
We found that both cortactin and Tks5 colocalized with the actin structures inside 
the agarose gel when the cells were compressed for 30 minutes (Figure 5-4A). However, 
due to the short compression time (30 minutes), we did not find that the actin protrusions 
could degrade the extracellular matrix (Figure 5-4B). By comparision, invadopodia 
structures are found to degrade the extracellular matrix in 15 hours [177].  
Figure 5-3: Actin protrusions at different agarose concentration 
Side view fluorescence images of actin structure in MCF-10A cells with different 




5.3.4 Role of Src signaling in the formation of actin protrusions under compression  
Src family kinases are critical in the formation of invadopodia. When Src kinase is 
activated by growth factors, they promote tyrosine phosphorylation of cortactin and Tks5, 
which are important steps during invadopodia formation [175, 187]. The phosphorylation 
Figure 5-4: Molecular structure and functions of the actin protrusions  
(A) Side view fluorescence images of the agarose gel, labeling cortactin and Tks5 
(green) and actin (red). Scale bar = 10 µm. (B) Fluorescence images of the actin 
(red) and DNA (blue) of cell and gelatin (green) using a gelatin degradation assay. 
Scale bar = 10 µm. 
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of these proteins leads to the recruitment of N-WASP, along with Arp2/3 complex, activate 
actin polymerization and invadopodia elongation [188]. Since invadopodia formation 
depends on Src signaling, we tested if Src inhibition can abolish the formation of actin 
protrusions. We found that in the presence of 20 µM of PP2, a Src inhibitor, actin 
protrusion formation was abolished (Figure 5-5A). This means that Src signaling might be 
important for the emergence of actin protrusions under compression.  
To further study whether mechanical compression leads to the activation of Src 
signaling, we performed Western blot analysis and directly looked at the protein level of 
Figure 5-5: Role of Src signaling in the formation of actin protrusions under 
compression 
(A) Side view fluorescence images of actin structure in MCF-10A cells, with and 
without PP2 an hour pre-treatment. Scale bar = 10 µm. (B) Western blot showing 
the phospho-Src and total Src for MCF-10A cells with and without compression. (C) 
Quantified and normalized change of phospho-Src activity for MCF-10A cells with 
and without compression. N = 3. 
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phosphorylated Src versus that of total Src. After applying compression for 30 minutes, the 
activity of phosphorylated Src showed a slight increase (Figure 5-5B, C). However, it was 
not a statistically significant change. Overall, from the drug inhibition and Western blot 
experiments, Src signaling may be one of the signaling pathways that is crucial for the 
formation of apical actin protrusions by compression. Further experiments are required to 
elucidate the molecular pathway by which compression induces apical actin protrusions. 
 
5.4 Conclusions 
In this work, I have discovered for the first time that actin protrusions form at the 
apical surface of epithelial cells following mechanical compression. The actin protrusions 
were found to form in mammary carcinoma cell as well and when 1% to 4% of agarose gel 
was used. The molecular structure of the actin protrusions was analyzed, and it was found 
that cortactin and Tks5 colocalized with the actin protrusions. By drug inhibition and 
Western blot analysis, Src signaling was shown to be important for the formation of actin 
protrusions and compression may lead to a local activation of Src.  
Cells in our body experience compression, however the effect of compression on 
cells have not been well characterized. In this work, we applied compression to epithelial 
cells and studied in detail the remodeling of actin cytoskeleton. The emergence of actin 
protrusions at the apical surface of the cell is a new discovery and this study has provided 
more insight into the molecular pathway involved in the formation of actin protrusions by 
compression. Overall, this work opens up new directions in studying the mechanism of 
actin protrusion formation by compression. 
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Chapter 6: Conclusions and future work 
 
6.1 Summary 
Compression, tension and shear are three types of mechanical input that cells in our 
body experience. Modulation of compression and inability for cells to balance the 
compression can lead to various diseases, such as pressure ulcers, hypertension, embolism, 
acute angle-closure glaucoma, and cancer. However, the understanding of how cells sense 
and respond to compression is not fully understood.  
To further advance our understanding of compression in mechanobiology, the 
development of new platforms and engineering tools play an important role in new 
scientific discoveries. In the development of mechanobiology, new scientific discovery 
often came with technological development that provides abilities to modulate mechanical 
inputs that cells experience and approaches to reduce the complex structures of living cells. 
In this dissertation, I endeavored to develop new experimental platform for studying 
mechanotransduction of compression in cells and further study the molecular responses of 
cells under compression using in vitro reconstitution and in single-cell and cell population 
systems. I first developed an in vitro reconstitution platform for constructing a simplified 
cell model that consists of bundled actin filaments or a cell-free expression system. I then 
developed a microfluidic device to mechanically trigger calcium influx in this simplified cell 
model. The microfluidic device was further optimized for applying compression force on 
single cells, so that the heterogeneous behaviors of cells can be studied. Finally, the 
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mechanosensing and mechanotransduction of actin cytoskeleton were studied in a cell 
monolayer system to characterize the apical actin protrusions in cells that experience 
normal compression. 
The cytoskeletal structures within the cell and between different cells are 
heterogeneous, making it very difficult to study the contribution of each cytoskeletal 
structure to the mechanical properties of cell. By developing a simplified but membrane-
confined model of a cell using a bottom-up reconstitution approach, I constructed a 
simplified yet insightful cell-like structure. Using double emulsion templated lipid vesicle 
technique, biomolecules can be encapsulated inside lipid vesicles. This opens up 
opportunities of forming various cellular network inside lipid vesicle. For example, actin 
bundles network was formed inside lipid vesicles. By varying different actin-binding 
proteins, different networks can be formed that interact with the lipid membrane, creating 
a more cell-like mechanical structure for future cell mechanics study. To better model the 
cytosol of a living cell, a cell-free expression system was used. The cell-free expression 
system is a biomolecular in vitro transcription and translation system using translation 
machinery extracted from HeLa cells for producing proteins. The feasibility of 
encapsulating the mammalian cell-free expression system inside lipid vesicle was 
demonstrated. I found that the double emulsion stabilization surfactant PVA was 
precipitating actin structures inside the cell-free system, leading to a reduction of protein 
production and instability of lipid vesicles. Overall, I endeavored to develop a new platform 
for constructing simplified model of a cell that can be used for cell mechanics studies.  
From working with bottom-up systems, I learned to appreciate the current 
challenges for constructing a simplified model of a cell using lipid bilayer vesicles. To 
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reduce the complexity even more, I used an alternative model system, double emulsion 
droplets, to prototype a mechano-responsive simplified model of a cell. To mechanically 
activate the simplified model of a cell, I developed a microfluidic device for the application 
of mechanical inputs, such as aspiration and compression. The developed microfluidic 
device utilized microvalves and microfluidic feature for trapping, applying aspiration and 
compression separately to the double emulsion droplets through air pressure-controlled 
valves. The device was carefully characterized and trapping, aspiration and compression of 
double emulsion droplets were demonstrated. After the development of the microfluidic 
device, I successfully demonstrated the removal of the middle phase oil which led to 
transport of calcium ions into the double emulsion droplets during hypo-osmotic shock. 
This is the first time that one has demonstrated mechanical activation of cell-like double 
emulsion droplets. The newly developed microfluidic platform opens up opportunities of 
mechanically regulating gene expression in a more complex cell-free expression 
encapsulated artificial cell.  
The newly developed microfluidic platform also allows mechanotransduction study 
in single cells to understand the heterogeneous responses of cells under compression. I 
modified the microfluidic device to provide a flat compressive surface by adding a 
rectangular block underneath the PDMS membrane. I also implemented microcontact-
printed fibronectin island underneath the rectangular block in order to control the 
spreading location of cells inside each compression chamber. The improved microfluidic 
device was characterized experimentally and by using simulation. After the development of 
the microfluidic device, I successfully demonstrated the static and cyclic compression of 
single cells that were seeded on the fibronectin islands. Due to the ability to trap and 
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compress multiple cells inside the microfluidic device, it opens up opportunity to study the 
heterogeneous mechanical properties and responses of single cells in a higher throughput 
manner. It also allows us to study different cellular responses under static and cyclic 
compression. 
Apart from the development of membrane-confined bottom-up reconstitution 
platform for potential cell mechanics study and microfluidic platform for both static and 
cyclic compression, I have further investigated the molecular responses of actin 
cytoskeleton under compression to understand the roles of actin in sensing and responding 
to compressive loading. Actin protrusions were found to form at the apical surface of the 
cell under high compression. The actin protrusions extended vertically in the direction 
towards the compression force. Cortactin and Tks5 were present in the actin protrusions, 
while no extracellular matrix degradation was found during the timeframe of compression. 
Src signaling was identified to be crucial for the formation of actin protrusions by 
compression. The discovery of actin protrusions suggests a possible invadopodia-like 
response under high compression and opens up new directions for the study of 
compression in cells.  
Overall, in this dissertation, I have developed two new emerging platforms for 
mechanobiology study and discovered actin cytoskeleton response under compression. 
The membrane-confined bottom-up reconstitution platform is a simplified yet insightful 
approach for constructing a simplified model of a cell that can be used for cell mechanics 
study. The microfluidic single-cell compression platform is a promising microtechnology 
for studying heterogeneous responses of single cells under static or cyclic compression and 
possibly other mechanotransduction studies. The newly discovered actin protrusion 
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response of cells under compression opens up new directions to explore whether this has 
any relevance in high stress tissues found in several diseases such as cancer. Altogether, 
the techniques developed and findings reported in this dissertation help advance our 
understanding of mechanobiology of compressed cells. 
 
6.2 Future work and perspectives 
6.2.1 Cell mechanics study using membrane-confined bottom-up reconstitution 
The membrane-confined bottom-up reconstitution platform allows the construction 
of different membrane-encapsulated cytoskeletal networks for cell mechanics study. In this 
dissertation, I did not apply mechanical forces to the constructed vesicle and measure its 
mechanical properties, such as elastic modulus, when different cytoskeletal networks were 
encapsulated. With the developed microfluidic device that allow the application of 
compression and aspiration of a cell-like model, we can measure the elasticity of the 
constructed vesicles. From this systematic investigation, we will be able to elucidate the 
role of confinement and network interaction with membrane on the elasticity of the 
cytoskeletal networks.  
The combination of membrane-confined bottom-up reconstitution and microfluidic 
platforms opens up the opportunities to construct cell-like structures and measure the 
corresponding material properties. While this approach simplifies the complex structures 
inside a living cell, it retained the cell-like property of membrane confinement. Therefore, 
the mechanical properties measured for these constructed vesicles will recapitulate that of 
a living cell better.  
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6.2.2 Further purification of mammalian cell-free expression for aggregate-free encapsulation 
in lipid vesicle 
In the dissertation, I investigated the possibility of encapsulating mammalian cell-
free expression, an in vitro transcription and translation system as the cytosol of artificial 
cells, inside lipid vesicles using double emulsion templated method. It was found that actin 
structures inside the cell-free expression system were aggregated in the presence of 
surfactant PVA, leading to the reduction in protein production.  
To resolve this issue, we can explore the possibility of further purifying the 
mammalian cell-free expression to remove actin. We can use antibody-coated beads that 
will bind to actin monomers as a way to pull down actin in the cell-free lysate. An actin-free 
mammalian cell-free expression system can potentially be compatible with the surfactant 
PVA and work as the cytosol for the artificial cell.  
While we have shown that encapsulation of bacterial cell-free expression system did 
not have a precipitation issue compared to the mammalian cell-free expression system, 
mammalian cell-free expression system still poses an advantage to be the cytosol of the 
artificial cell. The mammalian system provides a versatile platform to express mammalian 
proteins, which may require post-translational modification. Artificial cells synthesized 
using mammalian cell-free expression system can be used to study the function of 
mechanosensitive mammalian membrane proteins, such as Piezo1. Overall, resolving the 
issue of precipitation of mammalian cell-free expression system with surfactant PVA will 




6.2.3 Mechanical activation of artificial cell by microfluidics 
An alternative model system, double emulsion droplets, was used to prototype a 
mechano-responsive cell-like model in this dissertation, due to the challenges that we faced 
for constructing a membrane-confined artificial cell. After further development of the 
encapsulation of mammalian cell-free expression system inside lipid vesicles, we can 
construct artificial cells with mechanosensitive membrane proteins. The artificial cells can 
be programmed to sense mechanical stimulations and respond biochemically. For example, 
the artificial cell can sense compressive loading or an increase in membrane tension and 
translate this to a change in gene expression through the influx of secondary messengers 
into the artificial cell. To mechanically activate the artificial cell, a microfluidic device was 
developed in this dissertation to apply aspiration and compression to the artificial cells.  
According to Feynman’s idea of understanding: “That which I cannot create I do not 
understand” [189], the engineering of a mechanosensitive artificial cells becomes a testbed 
for us to further our understanding on the mechanosensing mechanism. With the help of 
the microfluidic device in applying mechanical loadings to the artificial cells, we will be able 
to test if we truly understand the mechanobiology of the simplified artificial cells that we 
engineered. 
 
6.2.4 Study of cell viscoelasticity and plasticity after static and cyclic compression 
The new microfluidic device was designed to apply compression on cells by 
increasing the air pressure applied to the Control valve set. This allows the cell to be 
compressed when the air pressure is high and relax when the air pressure is low. When the 
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pressure alternates between high and low values, the cell will experience repetitive 
compression and relaxation cycles.  
Most living cells show viscoelastic deformation under mechanical loading [190]. 
When the mechanical load was removed, the cell usually recovers partially to its original 
undeformed shape. The incomplete shape recovery is mainly due to the rupture of bond 
within the cytoskeleton, leading to the plasticity of cells [33, 191]. However, the 
cytoskeleton of the cell is anisotropic [192], organized by cytoskeletal filaments in different 
directions. Therefore, when a mechanical loading is applied, tensed regions will undergo 
plastic deformation, while compressed regions will not recover completely due to the 
inability to generate sufficient restoring forces after most of the elastic stresses have been 
evaded through buckling of the cytoskeletal fibers [33].  
The way how cells withstand planar compression was not very clear. Different 
structures inside the cells may withstand the planar compressive deformation, such as 
actin cortex along the plasma membrane, vertical actin fibers connecting the apical and 
basal surfaces of the cells and the mechanical stiffness of the nucleus. While it is still 
unclear how living cells recover after mechanical compression was removed, the new 
microfluidic device developed in this dissertation can be used to apply uniform and well-






6.2.5 Role of intercellular and traction forces in the activation of Src signaling under 
compression 
In this dissertation, it was found that actin protrusions form on the apical surface 
when cells were compressed. The invadopodia-like molecular structure and Src signaling 
involved for the actin protrusions were studied. In analyzing the presence of actin 
protrusions in a cluster of cells, my preliminary data shows that actin protrusions appeared 
more often in the middle of a cluster comparing to the outside. Previous work showed that 
the intercellular and traction forces exerted by the cells depend on the number of cell-cell 
contacts that each cell experiences [26]. Therefore, a future direction could be to study the 
roles of intercellular and traction forces in the activation of Src signaling under 
compression. We can measure the intercellular and traction forces using traction force 
microscopy [25, 26, 193]. A Src biosensor can be used to visualize the spatial differences in 
Src activity within a cluster of cell [194], and determine if the spatial variation correlates 
with that of the actin protrusions and the intercellular or traction forces.  
The intercellular and traction forces of the cell depend highly on the 
microenvironment. In this dissertation, we carried out the experiment on a 2D glass 
substrate. A future direction could be to characterize if actin protrusions form in 3D 
culturing context, that better recapitulates the microenvironment of a tumor. The 
investigation in this area will opens up questions of whether solid stress developed in 
tumor microenvironment is playing a role in the invasiveness of cancer cells as well as the 
tumorigenic transition of normal cells. 
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Overall, it is envisioned that the techniques developed and findings reported in this 
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